Generic Medicines
S. NO. | NAME OF PRODUCT | COMPOSITION | OFFICIAL PHARMACOPOEIA |
---|---|---|---|
1 | ACECLOFENAC TABLETS IP | EACH FILM COATED TABLET CONTAINS ACECLOFENAC IP 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
2 | CIPROFLOXACIN HYDROCHLORIDE TABLETS IP 500 MG | EACH FILM COATED TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE IP EQ TO CIPROFLOXACIN 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
3 | DICYCLOMINE HYDROCHLORIDE & PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS DICYCLOMINE HYDROCHLORIDE IP 20 MG PARACETAMOL IP 325 MG EXCIPIENTS Q.S. | |
4 | ETODOLAC 400 MG & PARACETAMOL 325 MG TABLETS | EACH FILM COATED TABLET CONTAINS ETODOLAC IP 400 MG PARACETAMOL IP 325 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
5 | PARACETAMOL TABLETS IP 500 MG | EACH UNCOATED TABLET CONTAINS PARACETAMOL IP 500 MG EXCIPIENTS Q.S. | IP |
6 | DROTAVERINE HYDROCHLORIDE TABLETS IP | EACH FILM COATED TABLET CONTAINS DROTAVERINE HYDROCHLORIDE IP 80 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
7 | DICLOFENAC SODIUM & PARACETAMOL TABLETS IP | EACH UNCOATED TABLET CONTAINS DICLOFENAC SODIUM IP 50 MG PARACETAMOL IP 500 MG EXCIPIENTS Q.S. | IP |
8 | DICLOFENAC GEL IP | COMPOSITION DICLOFENAC DIETHYLAMINE IP 1.16% W/W EQ TO DICLOFENAC SODIUM 1.00% W/W BENZYL ALCOHOL IP 1.00%W/W (AS PRESERVATIVE) GEL BASE Q.S. | IP |
9 | ISOTRETINOIN CAPSULES IP | EACH HARD GELATIN CAPSULE CONTAINS ISOTRETINOIN IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY CAPSULES SHELLS | IP |
10 | URSODEOXYCHOLIC ACID TABLETS IP 300 MG | EACH FILM COATED TABLET CONATINS URSODEOXYCHOLIC ACID IP 300 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
11 | DICLOFENAC DIETHYLAMINE, MENTHOL & METHYL SALICYLATE GEL | COMPOSITION DICLOFENAC DIETHYLAMINE IP 1.16% W/W EQ TO DICLOFENAC SODIUM 1.00% W/W MENTHOL IP 5.00% W/W METHYL SALICYLATE IP 10.00% W/W GEL BASE Q.S. | |
12 | ESCITALOPRAM OXALATE TABLETS IP | EACH FILM COATED TABLET CONTAINS ESCITALOPRAM OXALATE IP EQ. TO ESCITALOPRAM 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
13 | ITRACONAZOLE GEL 1% W/W | COMPOSITION ITRACONAZOLE BP 1.00% W/W METHYL PARABEN IP 0.10% W/W PROPYL PARABEN IP 0.05% W/W IN A GEL BASE Q.S. | |
14 | LOSARTAN POTASSIUM TABLETS IP 25 MG | EACH FILM COATED TABLET CONTAINS LOSARTAN POTTASIUM IP 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
15 | ESCITALOPRAM OXALATE TABLETS IP | EACH FILM COATED TABLET CONTAINS ESCITALOPRAM OXALATE IP EQ. TO ESCITALOPRAM 5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
16 | LEVETIRACETAM TABLETS BP | EACH FILM COATED TABLET CONTAINS LEVETIRACETAM IP 750 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
17 | ESOMEPRAZOLE GASTRO- RESISTANT TABLETS IP 40 MG | EACH ENTERIC COATED TABLET CONTAINS ESOMEPRAZOLE MAGNESIUM TRIHYDRATE IP EQ TO ESOMEPRAZOLE 40 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
18 | IVERMECTIN & ALBENDAZOLE TABLETS | EACH UNCOATED CHEWABLE TABLET CONTAINS IVERMECTIN IP 12 MG ALBENDAZOLE IP 400 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
19 | IVERMECTIN & ALBENDAZOLE TABLETS | EACH UNCOATED CHEWABLE TABLET CONTAINS IVERMECTIN IP 6 MG ALBENDAZOLE IP 400 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
20 | OMEPRAZOLE MAGNESIUM & DOMPERIDONE TABLETS | EACH ENTERIC COATED TABLET CONTAINS OMEPRAZOLE MAGNESIUM IP EQ TO OMEPRAZOLE 10 MG DOMPERIDONE IP 15 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
21 | ALBENDAZOLE AND IVERMECTIN SUSPENSION | EACH 5 ML CONTAINS ALBENDAZOLE IP 200 MG IVERMECTIN IP 1.5 MG FLAVOURED SYRUP BASE APPROVED COLOUR USED | |
22 | ACICLOVIR DISPERSIBLE TABLETS IP 800 MG | EACH DISPERSIBLE UNCOATED TABLET CONTAINS ACICLOVIR IP 800 MG EXCIPIENTS Q.S. | IP |
23 | LEVOCETIRIZINE DIHYDROCHLORIDE & MONTELUKAST TABLETS IP | EACH FILM COATED TABLET CONTAINS MONTELUKAST SODIUM IP EQ. TO MONTELUKAST 10 MG LEVOCETIRIZINE DIHYDROCHLORIDE IP 5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
24 | CIPROFLOXACIN HYDROCHLORIDE & ORNIDAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE IP EQ TO CIPROFLOXACIN 500 MG ORNIDAZOLE IP 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
25 | ALBENDAZOLE SUSPENSION IP | EACH 5 ML CONTAINS ALBENDAZOLE IP 200 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED | IP |
26 | PROPRANOLOL HYDROCHLORIDE (SR) & FLUNARIZINE DIHYDROCHLORIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS PROPRANOLOL HYDROCHLORIDE IP 40 MG (AS SUSTAINED RELEASE) FLUNARIZINE DIHYDROCHLORIDE BP EQ TO FLUNARIZINE 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATN CAPSULE SHELL | |
27 | ALBENDAZOLE CHEWABLE TABLETS IP 400 MG | EACH UNCOATED CHEWABLE TABLET CONTAINS ALBENDAZOLE IP 400 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
28 | AMBROXOL HYDROCHLORIDE, GUAIPHENESIN, TERBUTALINE SULPHATE & MENTHOL SYRUP | EACH 10 ML CONTAINS AMBROXOL HYDROCHLORIDE IP 30 MG GUAIPHENESIN IP 100 MG TERBUTALINE SULPHATE IP 2.5 MG MENTHOL IP 5 MG FLAVOURED SYRUPY BASE. Q.S. APPROVED COLOUR USED | |
29 | KETOROLAC TROMETHAMINE DISPERSIBLE TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS KETOROLAC TROMETHAMINE IP 10 MG EXCIPIENTS Q.S. | |
30 | NORTRIPTYLINE TABLETS IP | EACH FILM COATED TABLET CONTAINS NORTRIPTYLINE HYDROCHLORIDE IP EQ.TO NORTRIPTYLINE 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
31 | ACICLOVIR DISPERSIBLE TABLETS IP 400 MG | EACH DISPERSIBLE UNCOATED TABLET CONTAINS ACICLOVIR IP 400 MG EXCIPIENTS Q.S. | IP |
32 | CIPROFLOXACIN HYDROCHLORIDE TABLETS IP 250 MG | EACH FILM COATED TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE IP EQ TO CIPROFLOXACIN 250 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
33 | DICLOFENAC DIETHYLAMINE, OLIUM LINI,MENTHOL , METHYL SALICYLATE & BENZYL ALCOHOL GEL | COMPOSITION DICLOFENAC DIETHYLAMINE IP 1.16 % W/W EQ TO DICLOFENAC SODIUM 1.0 % W/W OLEUM LINI BP 3.0 % W/W (CONT. PREDOMINANTLY a-LINOLENIC ACID) METHYL SALICYLATE IP 10.0 % W/W MENTHOL IP 5.0 % W/W BENZYL ALCOHOL IP 1.0 % W/W (AS PERSERVATIVE) GEL BASE Q.S. | |
34 | PROPRANOLOL HYDROCHLORIDE SUSTIANED RELEASE TABLETS | EACH UNCOATED SUSTAINED RELEASE TABLET CONTAINS PROPRANOLOL HYDROCHLORIDE IP 20 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
35 | CIPROFLOXACIN AND TINIDAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE IP EQ TO CIPROFLOXACIN 500 MG TINIDAZOLE IP 600 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
36 | SILDENAFIL CITRATE TABLETS IP 100 MG | EACH FILM COATED TABLET CONTAINS SILDENAFIL CITRATE IP EQ.TO SILDENAFIL 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
37 | AMBROXOL HYDROCHLORIDE & CETIRIZINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS AMBROXOL HYDROCHLORIDE IP 60 MG CETIRIZINE HYDROCHLORIDE IP 5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
38 | LEVOCETIRIZINE HYDROCHLORIDE & PHENYLEPHRINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS LEVOCETIRIZINE HYDROCHLORIDE IP 2.5 MG PHENYLEPHRINE HYDROCHLORIDE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
39 | PROPRANOLOL HYDROCHLORIDE SUSTAINED RELEASE TABLETS | EACH SUSTAINED RELEASE UNCOATED TABLET CONTAINS PROPRANOLOL HYDROCHLORIDE IP 40 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
40 | FLUOXETINE HYDROCHLORIDE TABLETS IP | EACH UNCOATED TABLET CONTAINS FLUOXETINE HYDROCHLORIDE IP EQ TO FLUOXETINE 20 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
41 | PROPRANOLOL HYDROCHLORIDE (SUSTAINED RELEASE) & FLUNARIZINE DIHYDROCHLORIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS PROPRANOLOL HYDROCHLORIDE IP 40 MG (AS SUSTAINED RELEASE) FLUNARIZINE DIHYDROCHLORIDE BP EQ TO FLUNARIZINE 5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULES SHELLS | |
42 | PROPRANOLOL HYDROCHLORIDE TABLETS IP 10 MG | EACH UNCOATED TABLET CONTAINS PROPRANOLOL HYDROCHLORIDE IP 10 MG EXCIPIENTS Q. S APPROVED COLOUR USED | IP |
43 | PROPRANOLOL HYDROCHLORIDE (EXTENDED RELEASE) & FLUNARIZINE DIHYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS PROPRANOLOL HYDROCHLORIDE IP 40 MG (AS EXTENDED RELEASE) FLUNARIZINE DIHYDROCHLORIDE IP EQ TO FLUNARIZINE 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
44 | FLUOXETINE HYDROCHLORIDE CAPSULES IP 20 MG | EACH HARD GELATIN CAPSULE CONTAINS FLUOXETINE HYDROCHLORIDE IP EQ. TO FLUOXETINE 20 MG EXCIPIENT Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS | IP |
45 | ORNIDAZOLE & POVIDONE IODINE OINTMENT | COMPOSITION POVIDONE IODINE IP 5.0 % W/W (0.5%W/W AVAILABLE IODINE) ORNIDAZOLE IP 1.0 % W/W WATER SOLUBLE OINTMENT BASE Q.S. | |
46 | FLUOXETINE HYDROCHLORIDE CAPSULES IP | EACH HARD GELATIN CAPSULE CONTAINS FLUOXETINE HYDROCHLORIDE IP EQ. TO FLUOXETINE 1.0 MG EXCIPIENT Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS | IP |
47 | FLUOXETINE HYDROCHLORIDE TABLETS IP | EACH UNCOATED TABLET CONTAINS FLUOXETINE HYDROCHLORIDE IP EQ TO FLUOXETINE 0.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULES SHELLS | IP |
48 | PROPRANOLOL HYDROCHLORIDE TABLETS IP | EACH UNCOATED TABLET CONTAINS PROPRANOLOL HYDROCHLORIDE IP 0.5 MG EXCIPIENTS Q. S APPROVED COLOUR USED | IP |
49 | POVIDONE IODINE OINTMENT BP | COMPOSITION POVIDONE IODINE IP 5% W/W (0.5%W/W AVAILABLE IODINE) OINTMENT BASE Q.S. | USP |
50 | SUCRALFATE & POVIDONE IODINE OINTMENT | COMPOSITION POVIDONE IODINE IP 5.00% W/W (AVAILABLE IODINE 0.50% W/W SUCRALFATE IP 7.0% W/W WATER SOLUBLE OINTMENT BASE Q.S. | |
51 | POVIDONE IODINE OINTMENT BP | COMPOSITION POVIDONE IODINE IP 10.0 % W/W (1.0 %W/W AVAILABLE IODINE) WATER WASHABLE BASE Q.S. | USP |
52 | FLUOXETINE HYDROCHLORIDE TABLETS IP | EACH UNCOATED TABLET CONTAINS FLUOXETINE HYDROCHLORIDE IP EQ. TO FLUOXETINE 20 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
53 | AMBROXOL HYDROCHLORIDE, GUAIPHENESIN & PHENYLEPHRINE HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS AMBROXOL HYDROCHLORIDE IP 15 MG GUAIPHENESIN IP 50 MG PHENYLEPHRINE HYDROCHLORIDE IP 2.5 MG IN A FLAVOURED SYRUP BASE Q.S. APPROVED COLOUR USED | |
54 | AMLODIPINE & ATENOLOL TABLETS IP | EACH FILM COATED TABLET CONTAINS AMLODIPINE BESYLATE IP EQ. TO AMLODIPINE 5 MG ATENOLOL IP 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
55 | AMBROXOL HYDROCHLORIDE, GUAIPHENESIN, TERBUTALINE SULPHATE & MENTHOL SYRUP | EACH 5 ML CONTAINS AMBROXOL HYDROCHLORIDE IP 15 MG GUAIPHENESIN IP 50 MG TERBUTALINE SULPHATE IP 2.5 MG MENTHOL IP 2.5 MG FLAVOURED SYRUP BASE Q.S. APPROVED COLOUR USED | |
56 | TOPIRAMATE TABLETS IP 25 MG | EACH FILM COATED TABLET CONTAINS TOPIRAMATE IP 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
57 | OFLOXACIN & TINIDAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS OFLOXACIN IP 200 MG TINIDAZOLE IP 600 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
58 | TRANEXAMIC ACID & ETAMSYLATE TABLETS | EACH FILM COATED TABLET CONTAINS TRANEXAMIC ACID IP 250 MG ETAMSYLATE BP 250 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
59 | CINNARIZINE & DOMPERIDONE TABLETS | EACH UNCOATED TABLET CONTAINS CINNARIZINE IP 20 MG DOMPERIDONE IP 15 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
60 | AMLODIPINE & ATENOLOL TABLETS IP | EACH FILM COATED TABLET CONTAINS S-AMLODIPINE BESYLATE IP EQ TO S-AMLODIPINE 2.5 MG ATENOLOL IP 50 MG EXCIPIENTS Q.S. | IP |
61 | OLANZAPINE MOUTH DISSOLVING TABLETS | EACH MOUTH DISSOLVING UNCOATED TABLET CONTAINS OLANZAPINE IP 2.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
62 | ETORICOXIB TABLETS IP | EACH FILM COATED TABLET CONTAINS ETORICOXIB IP 60 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
63 | LEVOFLOXACIN TABLETS IP | EACH FILM COATED TABLET CONTAINS LEVOFLOXACIN HEMIHYDRATE IP EQ TO LEVOFLOXACIN 250 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
64 | CINNARIZINE TABLETS IP | EACH UNCOATED TABLET CONTAINS CINNARIZINE IP 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
65 | CINNARIZINE & DOMPERIDONE TABLETS | EACH UNCOATED TABLET CONTAINS CINNARIZINE IP 75 MG DOMPERIDONE IP 15 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
66 | ETORICOXIB TABLETS IP | EACH FILM COATED TABLET CONTAINS ETORICOXIB IP 120 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
67 | NORTRIPTYLINE TABLETS IP | EACH FILM COATED TABLET CONTAINS NORTRIPTYLINE HYDROCHLORIDE IP EQ.TO NORTRIPTYLINE 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
68 | BECLOMETHASONE DIPROPIONATE, CLOTRIMAZOLE & NEOMYCIN CREAM | COMPOSITION BECLOMETHASONE DIPROPIONATE IP 0.05 % W/W CLOTRIMAZOLE IP 1.00 % W/W NEOMYCIN SULPHATE IP EQ. TO NEOMYCIN BASE 0.50 % W/W CREAM BASE Q.S. | |
69 | AMLODIPINE TABLETS IP | EACH FILM COATED TABLET CONTAINS AMLODIPINE BESYLATE IP EQ. TO AMLODIPINE 5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
70 | OLANZAPINE MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS OLANZAPINE IP 15 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
71 | AMLODIPINE & TELMISARTAN TABLETS IP | EACH UNCOATED TABLET CONTAINS TELMISARTAN IP 40 MG AMLODIPINE BESYLATE IP EQ TO AMLODIPINE 5 MG EXCIPIENTS Q.S. | |
72 | CINNARIZINE TABLETS IP | EACH UNCOATED TABLET CONTAINS CINNARIZINE IP 75 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
73 | IVERMECTIN TABLET IP | EACH UNCOATED TABLET CONTAINS IVERMECTIN IP 12 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | U.S.P |
74 | AMLODIPINE TABLETS IP | EACH FILM COATED TABLET CONTAINS AMLODIPINE BESYLATE IP EQ.TO AMLODIPINE 2.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
75 | AMISULPRIDE TABLETS IP 50 MG | EACH UNCOATED TABLET CONTAINS AMISULPRIDE IP 50 MG EXCIPIENTS Q.S. | IP |
76 | OLANZAPINE MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS OLANZAPINE IP 5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
77 | TRIHEXYPHENIDYL HYDROCHLORIDE & TRIFLUOPERAZINE TABLETS | EACH FILM COATED TABLET CONTAINS TRIHEXYPHENIDYL HYDROCHLORIDE IP 2 MG TRIFLUOPERAZINE HYDROCHLORIDE IP EQ. TO TRIFLUOPERAZINE 5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
78 | LINEZOLID TABLETS IP 600 MG | EACH FILM COATED TABLET CONTAINS LINEZOLID IP 600 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
79 | SERTACONAZOLE NITRATE CREAM 2% W/W | COMPOSITION SERTACONAZOLE NITRATE IP 2.0 % W/W PRESERVATIVE BENZYL ALCOHOL IP 1.0% W/W CREAM BASE Q.S. | |
80 | ETORICOXIB & THIOCOLCHICOSIDE TABLETS | EACH FILM COATED TABLET CONTAINS ETORICOXIB IP 60 MG THIOCOLCHICOSIDE IP 4 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
81 | LINEZOLID ORAL SUSPENSION | EACH 5 ML RECONSTITUTED SUSPENSION CONTAINS LINEZOLID IP 100 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED | |
82 | TRIHEXYPHENIDYL HYDROCHLORIDE & RISPERIDONE TABLETS | EACH UNCOATED TABLET CONTAINS RISPERIDONE IP 2 MG TRIHEXYPHENIDYL HYDROCHLORIDE IP 2 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
83 | LINEZOLID TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS LINEZOLID IP 400 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
84 | IVERMECTIN CREAM | COMPOSITION IVERMECTIN IP 1.00%W/W CREAM BASE Q.S. | |
85 | IVERMECTIN TABLET IP | EACH UNCOATED TABLET CONTAINS IVERMECTIN IP 6 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
86 | TELMISARTAN & HYDROCHLORTHIAZIDE TABLETS IP | EACH FILM COATED TABLET CONTAINS TELMISARTAN IP 80 MG HYDROCHLORTHIAZIDE IP 12.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
87 | IVERMECTIN SHAMPOO | COMPOSITION IVERMECTIN IP 0.50%W/V AQUEOUS BASE Q.S. APPROVED COLOUR USED | |
88 | TRIHEXYPHENIDYL HYDROCHLORIDE TABLETS IP | EACH UNCOATED TABLET CONTAINS TRIHEXYPHENIDYL HYDROCHLORIDE IP 2 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
89 | TELMISARTAN & CHLORTHALIDONE TABLETS | EACH FILM COATED TABLET CONTAINS TELMISARTAN IP 40 MG CHLORTHALIDONE IP 12.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
90 | RISPERIDONE &TRIHEXYPHENIDYL HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS RISPERIDONE IP 3 MG TRIHEXYPHENIDYL HYDROCHLORIDE IP 2 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
91 | TELMISARTAN TABLETS IP | EACH UNCOATED TABLET CONTAINS TELMISARTAN IP 40 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
92 | TELMISARTAN & HYDROCHLORTHIAZIDE TABLETS IP | EACH FILM COATED TABLET CONTAINS TELMISARTAN IP 40 MG HYDROCHLOROTHIAZIDE IP 12.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
93 | FLUVOXAMINE MALEATE SUSTIANED RELEASE TABLETS | EACH UNCOATED SUSTAINED RELEASE TABLET CONTAINS FLUVOXAMINE MALEATE BP 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
94 | AMISULPRIDE TABLETS IP | EACH UNCOATED TABLET CONTAINS AMISULPRIDE IP 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
95 | CYPROHEPTADINE HYDROCHLORIDE SYRUP IP | EACH 5 ML CONTAINS CYPROHEPTADINE HYDROCHLORIDE IP 2 MG (ANHYDROUS) FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED | IP |
96 | SUCRALFATE, METRONIDAZOLE & LIGNOCAINE HYDROCHORIDE CREAM | COMPOSITION SUCRALFATE IP 7.0%W/W METRONIDAZOLE IP 1.00%W/W LIGNOCAINE HYDROCHLORIDE IP 4.0%W/W CREAM BASE Q.S. | |
97 | SUCRALFATE, METRONIDAZOLE & POVIDONE IODINE OINTMENT | COMPOSITION SUCRALFATE BP 7.0%W/W METRONIDAZOLE IP 1.00%W/W POVIDONE IODINE IP 5.0%W/W (AVIALABLE IODINE 0.50%W/W) IN OINTMENT BASE Q.S. | |
98 | ARTEMETHER & LUMEFENTRINE TABLETS IP | EACH UNCOATED TABLET CONTAINS ARTEMETHER IP 80 MG LUMEFANTRINE IP 480 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
99 | ARTEMETHER & LUMEFENTRINE TABLETS IP | EACH UNCOATED DISPERSIBLE TABLET CONTAINS ARTEMETHER IP 40 MG LUMEFANTRINE IP 240 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
100 | ISOXSUPRINE HYDROCHLORIDE TABLETS IP | EACH UNCOATED TABLET CONTAINS ISOXSUPRINE HYDROCHLORIDE IP 20 MG EXCIPIENTS Q.S. | IP |
101 | AMOROLFINE HYDROCHLORIDE CREAM | COMPOSITION AMOROLFINE HYDROCHLORIDE IP EQ. TO AMOROLFINE 0.25%W/W CREAM BASE Q.S. | |
102 | AMITRIPTYLINE HYDROCHLORIDE TABLETS IP | EACH FILM COATED TABLET CONTAINS AMITRIPTYLINE HYDROCHLORIDE IP EQ TO AMITRIPTYLINE 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
103 | AMITRIPTYLINE HYDROCHLORIDE TABLETS IP | EACH FILM COATED TABLET CONTAINS AMITRIPTYLINE HYDROCHLORIDE IP EQ TO AMITRIPTYLINE 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
104 | ISOXSUPRINE HYDROCHLORIDE TABLETS IP | EACH UNCOATED TABLET CONTAINS ISOXSUPRINE HYDROCHLORIDE IP 10 MG EXCIPIENTS Q.S. | IP |
105 | FLUVOXAMINE MALEATE TABLETS IP | EACH FILM COATED TABLET CONTAINS FLUVOXAMINE MALEATE IP 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
106 | SILYMARIN TABLETS | EACH FILM COATED TABLET CONTAINS SILYMARIN 70 MG (AS SILYBIN) EXCIPIENTS Q.S. APPROVED COLOUR USED | |
107 | CYPROHEPTADINE HYDROCHLORIDE & TRICHOLINE CITRATE DROPS | EACH ML CONTAINS CYPROHEPTADINE HCL IP 1.5 MG (ANHYDROUS) TRICHOLINE CITRATE (65%) IP 55 MG FLAVOURED NON SYRUP BASE Q.S. APPROVED COLOUR USED | |
108 | HALOBETASOLE PROPIONATE & SALICYLIC ACID OINTMENT | COMPOSITION HALOBETASOLE PROPIONATE USP 0.05% W/W SALICYLIC ACID IP 6.0% W/W OINTMENT BASE Q.S. | |
109 | CLINDAMYCIN PHOSPHATE GEL BP | COMPOSITION CLINDAMYCIN PHOSPHATE IP EQ. TO CLINDAMYCIN 1% W/W PRESERVATIVE SODIUM METHYL PARABEN IP 0.114% W/W SODIUM PROPYL PARABEN IP 0.056% W/W GEL BASE Q.S. | BP |
110 | CLOBAZAM TABLETS IP | EACH UNCOATED TABLET CONTAINS CLOBAZAM IP 10 MG EXCIPIENTS Q.S. | IP |
111 | ISOXSUPRINE SUSTAINED RELEASE TABLETS | EACH UNCOATED SUSTAINED RELEASE TABLET CONTAINS ISOXSUPRINE HYDROCHLORIDE IP 40 MG EXCIPIENTS Q.S. | |
112 | SILYMARIN TABLETS | EACH FILM COATED TABLET CONTAINS SILYMARIN 140 MG (AS SILYBIN) EXCIPIENTS Q.S. APPROVED COLOUR USED | |
113 | ISOXSUPRINE HYDROCHLORIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS ISOXSUPRINE HYDROCHLORIDE IP 20 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN HARD GELATIN CAPSULES SHELL | |
114 | CHOLINE SALICYLATE, LIGNOCAINE HYDROCHLORIDE & BENZALKONIUM CHLORIDE GEL GEL | COMPOSITION CHOLINE SALICYLATE SOLUTION BP EQ.TO CHOLINE SALICYLATE 8.70% W/W LIGNOCAINE HYDROCHLORIDE IP 2.00% W/W BENZALKONIUM CHLORIDE SOLUTION IP 0.01% W/W (AS PRESERVATIVE) IN PLEASANT FLAVOURED GEL BASE Q.S. | |
115 | MEFENAMIC ACID & DICYCLOMINE HYDROCHLORIDE TABLETS IP | EACH UNCOATED TABLET CONTAINS MEFENAMIC ACID IP 250 MG DICYCLOMINE HYDROCHLORIDE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
116 | GAMMABENZENE HEXACHLORIDE & CETRIMIDE LOTION | COMPOSITION GAMMABENZENE HEXACHLORIDE IP 1.0% W/V CETRIMIDE IP 0.1% W/V IN EMULSION BASE Q.S. | |
117 | SILYMARIN SUSPENSION | EACH 5 ML CONTAINS SILYMARIN (AS SILYBIN) 35 MG FLAVOURED SYRUP BASE Q.S. APPROVED COLOUR USED | |
118 | CYPROHEPTADINE HYDROCHLORIDE TABLETS IP | EACH UNCOATED TABLET CONTAINS CYPROHEPTADINE HYDROCHLORIDE IP EQ, TO CYPROHEPTADINE(ANHYDROUS) 4 MG EXCIPIENTS Q.S. | IP |
119 | CHLORDIAZEPOXIDE TABLET IP | EACH FILM COATED TABLET CONTAINS CHLORDIAZEPOXIDE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
120 | WHITE SOFT PARAFFIN & LIGHT LIQUID PARAFFIN CREAM | COMPOSITION WHITE SOFT PARAFFIN IP 13.2% W/W LIGHT LIQUID PARAFFIN IP 10.2% W/W CREAM BASE Q.S. | |
121 | TRICHOLINE CITRATE & SORBITOL SOLUTION | EACH 5 ML CONTAINS TRICHOLINE CITRATE (65%) 275 MG SORBITOL SOLUTION (70%) IP 3.5 GM FLAVOURED SYRUP BASE Q.S. APPROVED COLOUR USED | |
122 | HALOBETASOLE PROPIONATE & SALICYLIC ACID OINTMENT | COMPOSITION HALOBETASOLE PROPIONATE BP 0.05% W/W SALICYLIC ACID IP 2.0% W/W OINTMENT BASE Q.S. | |
123 | PRIMAQUINE PHOSPHATE DISPERSIBLE TABLETS IP | EACH UNCOATED DISPERSIBLE TABLET CONTAINS PRIMAQUINE PHOSPHATE IP EQ TO PRIMAQUINE 2.5 MG EXCIPIENTS Q.S. | IP |
124 | SALICYLIC ACID OINTMENT IP | COMPOSITION SALICYLIC ACID IP 12.0% W/W OINTMENT BASE Q.S. | IP |
125 | DI-SODIUM HYDROGEN CITRATE SYRUP | EACH 5 ML CONTAINS DI-SODIUM HYDROGEN CITRATE BP 1.38 MG FLAVOURED SYRUP BASE Q.S. APPROVED COLOUR USED | |
126 | CLINDAMYCIN & NICOTINAMIDE GEL | COMPOSITION CLINDAMYCIN PHOSPHATE IP EQ. TO CLINDAMYCIN 1.0% W/W NICOTINAMIDE IP 4.0% W/W IN ALOE, ALLANTION BASE WITH ETHYL LACTATE GEL BASE Q.S. | |
127 | PAROXETINE HYDROCHLORIDE PROLONGED RELEASE TABLETS IP | EACH FILM COATED PROLONGED RELEASE TABLET CONTAINS PAROXETINE HYDROCHLORIDE IP EQ TO PAROXETINE 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
128 | CALAMINE & ZINC OXIDE SKIN LOTION IP | COMPOSITION CALAMINE IP 15 % W/V ZINC OXIDE IP 5 % W/V AQUEOUS BASE Q.S. | IP |
129 | SERTRALINE HYDROCHLORIDE TABLETS IP 100 Mg | EACH FILM COATED TABLET CONTAINS SERTRALINE HYDROCHLORIDE IP EQ TO SERTRALINE 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
130 | RISPERIDONE ORALLY DISINTEGRATING TABLETS IP | EACH ORALLY DISINTEGRATING TABLET CONTAINS RISPERIDONE IP 2 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
131 | PAROXETINE HYDROCHLORIDE TABLETS IP | EACH FILM COATED TABLET CONTAINS PAROXETINE HYDROCHLORIDE HEMIHYDRATE IP EQ TO PAROXETINE 20 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
132 | LEVETIRACETAM TABLETS IP 500 MG | EACH FILM COATED TABLET CONTAINS LEVETIRACETAM IP 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
133 | RISPERIDONE MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS RISPERIDONE IP 1.0 MG EXCIPIENTS Q.S. | |
134 | DESVENLAFAXINE GASTRO-RESISTANT TABLETS | EACH FILM COATED GASTRO-RESISTANT TABLET CONTAINS DESVENLAFAXINE SUCCINATE EQ. TO DESVENLAFAXINE 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
135 | CHLORDIAZEPOXIDE TABLETS IP | EACH FILM COATED TABLET CONTAINS CHLORDIAZEPOXIDE IP 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
136 | DIVALPROEX SODIUM GASTRO-RESISTANT TABLETS IP 250 MG | EACH ENTERIC-COATED GASTRO-RESISTANT TABLET CONTAINS DIVALPROEX SODIUM IP EQ TO VALPROIC ACID 250 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
137 | PRIMAQUINE PHOSPHATE TABLETS IP | EACH FILM COATED TABLET CONTAINS PRIMAQUINE PHOSPHATE IP EQ TO PRIMAQUINE 7.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
138 | DIVALPROEX SODIUM GASTRO-RESISTANT TABLETS IP 500 MG | EACH ENTERIC-COATED GASTRO-RESISTANT TABLET CONTAINS. DIVALPROEX SODIUM IP EQ TO VALPROIC ACID 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
139 | PRIMAQUINE PHOSPHATE TABLETS IP | EACH FILM COATED TABLET CONTAINS PRIMAQUINE PHOSPHATE IP EQ TO PRIMAQUINE 15 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
140 | SODIUM VALPROATE & VALPROIC ACID CONTROLLED RELEASE TABLETS | EACH FILM COATED CONTROLLED RELEASE TABLET CONTAINS SODIUM VALPROATE IP 200 MG VALPROIC ACID IP 87 MG (BOTH TOGETHER CORRESPONDS TO SODIUM VALPROATE 300 MG) EXCIPIENTS Q.S. APPROVED COLOUR USED | |
141 | PAROXETINE HYDROCHLORIDE PROLONGED-RELEASE TABLETS IP 12.5 MG | EACH FILM COATED PROLONGED-RELEASE TABLET CONTAINS PAROXETINE HYDROCHLORIDE IP EQ TO PAROXETINE 12.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
142 | SODIUM VALPROATE GASTRO-RESISTANT TABLETS IP | EACH ENTERIC COATED TABLET CONTAINS SODIUM VALPROATE IP 200 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
143 | ARIPIPRAZOLE TABLETS IP 10 MG | EACH UNCOATED TABLET CONTAINS ARIPIPRAZOLE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
144 | POTASSIUM NITRATE, SODIUM MONOFLUOROPHOSPHATE TRICLOSAN TOOTH PASTE | COMPOSITION POTASSIUM NITRATE BP 5.0% W/W SODIUM MONOFLUOROPHOSPHATE USP 0.7% W/W TRICLOSAN USP 0.3% W/W IN A PLEASANTLY FLAVOURED BASE Q.S. (AVAILABLE FLUORIDE CONTENT 917 PPM WHEN PACKED) APPROVED COLOUR USED | |
145 | FLUNARIZINE TABLETS IP 10 MG | EACH UNCOATED TABLET CONTAINS FLUNARIZINE DIHYDROCHLORIDE IP EQ TO FLUNARIZINE 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
146 | SERTRALINE HYDROCHLORIDE TABLETS IP 50 MG | EACH FILM COATED TABLET CONTAINS SERTRALINE HYDROCHLORIDE IP EQ TO SERTRALINE 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
147 | MIRTAZAPINE TABLETS IP 7.5 MG | EACH FILM COATED TABLET CONTAINS MIRTAZAPINE IP 7.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
148 | PROPRANOLOL HYDROCHLORIDE TABLETS IP 20 MG | EACH UNCOATED TABLET CONTAINS PROPRANOLOL HYDROCHLORIDE IP 20 MG EXCIPIENTS Q.S. | IP |
149 | SERTRALINE HYDROCHLORIDE TABLETS IP 25 MG | EACH FILM COATED TABLET CONTAINS SERTRALINE HYDROCHLORIDE IP EQ TO SERTRALINE 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
150 | CHLORBUTOL, BENZOCAINE & PARADICHLOROBENZENE EAR DROPS | COMPOSITION CHLORBUTOL IP 5.00% W/W BENZOCAINE IP 2.50% W/W PARADICHLOROBENZENE 2.00% W/W NON AQUEOUS BASE Q.S. | |
151 | FLUNARIZINE TABLETS IP 5 MG | EACH UNCOATED TABLET CONTAINS FLUNARIZINE DIHYDROCHLORIDE IP EQ.TO FLUNARIZINE 5 MG EXCIPIENTS Q.S. | IP |
152 | ARIPIPRAZOLE TABLETS IP 15 MG | EACH UNCOATED TABLET CONTAINS ARIPIPRAZOLE IP 15 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
153 | DESVENLAFAXINE SUCCINATE EXTENDED RELEASE TABLETS 50 MG | EACH FILM COATED EXTENDED RELEASE TABLET CONTAINS DESVENLAFAXINE SUCCINATE EQ TO DESVENLAFAXINE 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
154 | QUETIAPINE TABLET IP 50 MG | EACH FILM COATED TABLET CONTAINS QUETIAPINE FUMARATE IP EQ TO QUETIAPINE 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
155 | SALBUTAMOL & THEOPHYLLINE TABLETS | EACH UNCOATED TABLET CONTAINS THEOPHYLLINE (ANHYDROUS) IP 100 MG SALBUTAMOL SULPHATE IP EQ. TO SALBUTAMOL 4 MG EXCIPIENTS Q.S. | |
156 | QUETIAPINE TABLETS IP 200 MG | EACH FILM COATED TABLET CONTAINS QUETIAPINE FUMARATE IP EQ TO QUETIAPINE 200 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
157 | PERMETHRIN LOTION | COMPOSITION PERMETHRIN 5 % W/V LOTION BASE Q.S. | |
158 | OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTION IP 0.05%W/V | COMPOSITION OXYMETAZOLINE HYDROCHLORIDE IP 0.05% W/V PRESERVATIVE BENZALKONIUM CHLORIDE SOLUTION IP 0.01% W/V IN A BUFFERED AQUEOUS SOLUTION Q.S. | IP |
159 | ARIPIRAZOLE TABLETS IP 5 MG | EACH UNCOATED TABLET CONTAINS ARIPIPRAZOLE IP 5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
160 | DULOXETINE GASTRO-RESISTANT TABLETS IP | EACH ENTERIC COATED TABLET CONTAINS DULOXETINE HYDROCHLORIDE IP EQ TO DULOXETINE 30 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
161 | DIETHYLCARBAMAZINE CITRATE & CHLORPHENIRAMINE MALEATE TABLETS | EACH FILM COATED TABLET CONTAINS DIETHYLCARBAMAZINE CITRATE IP 150 MG CHLORPHENIRAMINE MALEATE IP 2.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
162 | ARIPIPRAZOLE TABLETS IP | EACH UNCOATED TABLET CONTAINS ARIPIPRAZOLE IP 30 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
163 | LOSARTAN POTASSIUM & HYDROCHLORTHIAZIDE TABLETS IP | EACH FILM COATED TABLET CONTAINS LOSARTAN POTASSIUM IP 25 MG HYDROCHLORTHIAZIDE IP 12.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
164 | DOXEPIN HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS DOXEPIN HYDROCHLORIDE IP EQ TO DOXEPIN 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
165 | QUETIAPINE TABLET IP 100 MG | EACH FILM COATED TABLET CONTAINS QUETIAPINE FUMARATE IP EQ TO QUETIAPINE 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
166 | LAMOTRIGINE DISPERSIBLE TABLETS IP 50 MG | EACH UNCOATED DISPERSIBLE TABLET CONTAINS LAMOTRIGINE IP 50 MG (IN A FLAVORED BASE) EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
167 | IMIPRAMINE HYDROCHLORIDE TABLET IP | EACH FILM COATED TABLET CONTAINS IMIPRAMINE HYDROCHLORIDE IP 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
168 | QUETIAPINE TABLET IP 25 MG | EACH FILM COATED TABLET CONTAINS QUETIAPINE FUMARATE IP EQ TO QUETIAPINE 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
169 | DOMPERIDONE SUSPENSION IP | EACH ML CONTAINS DOMPERIDONE IP 1 MG IN FLAVOURED SYRUP BASE Q.S. APPROVED COLOUR USED | IP |
170 | MICONAZOLE NITRATE & FLUOCINOLONE ACETONIDE CREAM | COMPOSITION FLUOCINOLONE ACETONIDE IP 0.01% W/W MICONAZOLE NITRATE IP 2.0% W/W CREAM BASE Q.S. | |
171 | DULOXETINE GASTRO-RESISTANT TABLETS IP | EACH ENTERIC COATED TABLET CONTAINS DULOXETINE HYDROCHLORIDE IP EQ. TO DULOXETINE 20 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
172 | CLOMIPRAMINE HYDROCHLORIDE TABLETS 25 MG | EACH FILM COATED TABLET CONTAINS CLOMIPRAMINE HYDROCHLORIDE IP 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
173 | HALOPERIDOL DISPERSIBLE TABLET IP 5 MG. | EACH DISPERSIBLE UNCOATED TABLET CONTAINS HALOPERIDOL IP 5 MG EXCIPIENTS Q.S. | IP |
174 | DIPHENOXYLATE HYDROCHLORIDE & ATROPINE SULPHATE IP | EACH UNCOATED TABLET CONTAINS DIPHENOXYLATE HYDROCHLORIDE IP 2.5 MG ATROPINE SULPHATE IP 0.025 MG EXCIPIENTS Q.S. | IP |
175 | CARISOPRODOL TABLETS IP 350 MG | EACH UNCOATED TABLET CONTAINS CARISOPRODOL IP 350 MG EXCIPIENTS Q.S. | IP |
176 | LEFLUNOMIDE TABLETS IP | EACH FILM COATED TABLET CONTAINS LEFLUNOMIDE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
177 | GLIMEPIRIDE TABLETS IP 2 MG | EACH UNCOATED TABLET CONTAINS GLIMEPIRIDE IP 2 MG EXCIPIENTS Q.S. | IP |
178 | DICYCLOMINE HYDROCHLORIDE & SIMETHICONE SUSPENSION | EACH ML CONTAINS DICYCLOMINE HYDROCHLORIDE IP 10 MG SIMETHICONE IP 40 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED | |
179 | DOXEPIN HYDROCHLORIDE TABLETS 75 MG | EACH FILM COATED TABLET CONTAINS DOXEPINE HYDROCHLORIDE IP EQ TO DOXEPIN 75 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
180 | HALOPERIDOL TABLET IP | EACH UNCOATED TABLET CONTAINS HALOPERIDOL IP 1.5 MG EXCIPIENTS Q.S. | IP |
181 | DIPHENHYDRAMINE HYDROCHLORIDE, AMMONIUM CHLORIDE, SODIUM CITRATE & MENTHOL SYRUP | EACH 5 ML CONTAINS DIPHENHYDRAMINE HYDROCHLORIDE IP 14.08 MG AMMONIUM CHLORIDE IP 138 MG SODIUM CITRATE IP 100 MG MENTHOL IP 1.14 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED | |
182 | THYMOL, MENTHOL, ICHTHAMMOL & LIGNOCAINE HCl OINTMENT | COMPOSITION THYMOL IP 0.50%W/W MENTHOL IP 0.20%W/W ICHTHAMMOL BP 1.00%W/W LIGNOCAINE HYDROCHLORIDE IP 1.00%W/W IN OINTMENT BASE Q.S. | |
183 | PERMETHRIN CREAM | EACH GM CREAM CONTAINS PERMETHRIN 50 MG CREAM BASE Q.S. | |
184 | CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS DEXTROMETHORPHAN HYDROBROMIDE IP 10 MG PHENYLEPHRINE HYDROCHLORIDE IP 5 MG CHLORPHENIRAMINE MALEATE IP 2 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED | |
185 | IMIPRAMINE HYDROCHLORIDE TABLET IP 25 MG | EACH FILM COATED TABLET CONTAINS IMIPRAMINE HYDROCHLORIDE IP 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
186 | DICLOFENAC DIETHYLAMINE, LINSEED OIL, MENTHOL & METHYL SALICYLATE GEL | COMPOSITION DICLOFENAC DIETHYLAMINE IP 1.16% W/W EQ. TO DICLOFENAC SODIUM 1.00% W/W LINSEED OIL BP 3.000 % W/W MENTHOL IP 0.50% W/W METHYL SALICYLATE IP 10.000% W/W GEL BASE Q.S. | |
187 | CLOMIPRAMINE HYDROCHLORIDE TABLETS 50 MG | EACH FILM COATED TABLET CONTAINS CLOMIPRAMINE HYDROCHLORIDE IP 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
188 | TACROLIMUS OINTMENT | COMPOSITION TACROLIMUS IP 0.03 % W/W OINTMENT BASE Q.S. | |
189 | LAMOTRIGINE DISPERSIBLE TABLETS IP | EACH UNCOATED DISPERSIBLE TABLET CONTAINS LAMOTRIGINE IP 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
190 | ACECLOFENAC & THIOCOLCHICOSIDE TABLETS | EACH FILM COATED TABLET CONTAINS ACECLOFENAC IP 100 MG THIOCOLCHICOSIDE IP 8 MG EXCIPIENTS Q.S. APPROVED COLOURED USED | |
191 | TOPIRAMATE TABLETS IP | EACH FILM COATED TABLET CONTAINS TOPIRAMATE IP 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
192 | OLANZAPINE MOUTH DISSOLVING TABLETS 10 MG | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS OLANZAPINE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
193 | GAMMABENZENE HEXACHLORIDE & CETRIMIDE LOTION | COMPOSITION GAMMABENZENE HEXACHLORIDE IP 1.0 % W/V CETRIMIDE IP 0.06% W/V IN EMULSION BASE Q.S. | |
194 | GAMMABENZENE HEXACHLORIDE LOTION | COMPOSITION GAMMA BENZENE HEXACHLORIDE IP 1.0 % W/V IN AQUEOUS BASE Q.S. | |
195 | SPARFLOXACIN TABLETS 200 MG | EACH FILM COATED TABLET CONTAINS SPARFLOXACIN 200 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
196 | POTASSIUM CITRATE MONOHYDRATE, CITRIC ACID MONOHYDRATE SOLUTION BP | EACH 5 ML CONTAINS POTASSIUM CITRATE MONOHYDRATE IP 1100 MG CITRIC ACID MONOHYDRATE IP 334 MG FLAVOURED BASE Q.S. APPROVED COLOUR USED | U.S.P |
197 | VENLAFAXINE HYDROCHLORIDE EXTEND RELEASE TABLETS | EACH UNCOATED EXTENDE RELEASE TABLET CONTAINS VENLAFAXINE HYDROCHLORIDE BP EQ TO VENLAFAXINE 75 MG EXCIPIENTS Q.S. | |
198 | TACROLIMUS OINTMENT | COMPOSITION TACROLIMUS IP 0.01 % W/W OINTMENT BASE Q.S. | |
199 | LIGNOCAINE HYDROCHLORIDE GEL IP | COMPOSITION LIGNOCAINE HYDROCHLORIDE IP 2.00%W/W METHYL PARABEN IP 0.061%W/W PROPYL PARABEN IP 0.027%W/W IN A WATER SOLUBLE GEL BASE Q.S. | IP |
200 | LEVAMISOLE TABLET IP | EACH UNCOATED TABLET CONTAINS LEVAMISOLE HYDROCHLORIDE IP EQ TO LEVAMISOLE 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
201 | PARACETAMOL & ETODOLAC TABLETS | EACH FILM COATED TABLET CONTAINS ETODOLAC IP 400 MG PARACETAMOL IP 200 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
202 | ISOSORBIDE MONONITRATE TABLETS IP | EACH UNCOATED TABLET CONTAINS DILUTED ISOSORBIDE MONONITRATE IP EQ TO ISOSORBIDE 20 MG EXCIPIENTS Q.S. | IP |
203 | HYDROXYZINE HYDROCHLORIDE TABLETS IP 25 MG | EACH FILM COATED TABLET CONTAINS HYDROXYZINE HYDROCHLORIDE IP 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
204 | UREA, LACTIC ACID, PROPYLENE GLYCOL & LIQUID PARAFFIN CREAM | COMPOSITION UREA IP 10.0%W/W LACTIC ACID IP 10.0%W/W PROPYLENE GLYCOL IP 10.0%W/W LIQUID PARFAFFIN IP 10.0%W/W IN ACREAML BASE Q.S. | |
205 | MINOCYCLINE TABLETS BP | EACH UNCOATED TABLET CONTAINS MINOCYCLINE HYDROCHLORIDE BP EQ TO MINOCYCLINE 100 MG EXCIPIENTS Q.S. | BP |
206 | LACTULOSE SOLUTION BP | EACH 5ML CONTAINS LACTULOSE CONCENTRATE BP EQ. TO LACTULOSE 3.335 GM FLAVOURED SYRUP BASE Q.S. | BP |
207 | DEXAMETHASONE TABLETS IP | EACH UNCOATED TABLET CONTAINS DEXAMETHASONE IP 0.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
208 | IBUPROFEN & PARACETAMOL TABLETS IP | EACH FILM COATED TABLET CONTAIN IBUPROFEN IP 400 MG PARACETAMOL IP 325 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
209 | SULFASALAZINE DELAYED RELEASE TABLETS BP 500 MG | EACH ENTERIC COATED TABLET CONTAINS SULFASALAZINE BP 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | BP |
210 | BUDESONIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS BUDESONIDE IP 3 MG (AS CONTROLLED RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULES SHELLS & PELLETS | |
211 | BISACODYL TABLETS IP | EACH ENTERIC COATED TABLET CONTAINS BISACODYL IP 5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
212 | HYDROXYCHLOROQUINE SULPHATE TABLETS IP | EACH FILM COATED TABLET CONTAINS HYDROXYCHLOROQUINE SULPHATE IP 200 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
213 | TRIOXSALEN TABLETS BP 25 MG | EACH FILM COATED TABLET CONTAINS TRIOXSALEN BP 25 MG EXCIPIENT Q.S. APPROVED COLOUR USED | BP |
214 | CHLORPHENIRAMINE MALEATE TABLETS IP | EACH UNCOATED TABLET CONTAINS CHLORPHENIRAMINE MALEATE IP 4 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
215 | ETOFYLLINE, BROMHEXINE HYDROCHLORIDE & SALBUTAMOL SULPHATE TABLETS | EACH UNCOATED TABLET CONTAINS SALBUTAMOL SULPHATE IP EQ TO SALBUTAMOL 4 MG ETOPHYLLINE (ANHYDROUS) BP 200 MG BROMHEXINE HYDROCHLORIDE IP 16 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
216 | LEVETIRACETAM TABLETS IP | EACH FILM COATED TABLET CONTAINS LEVETIRACETAM IP 250 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
217 | LEVETIRACETAM TABLES IP | EACH FILM COATED TABLET CONTAINS LEVETIRACETAM IP 1000 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
218 | LOSARTAN POTASSIUM TABLETS IP | EACH FILM COATED TABLET CONTAINS LOSARTAN POTTASIUM IP 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
219 | DICLOFENAC DIETHYLAMINE, LINSEED OIL,MENTHOL , METHYL SALICYLATE & BENZYL ALCOHOL GEL | COMPOSITION DICLOFENAC DIETHYLAMINE IP 1.16% W/W EQ TO DICLOFENAC SODIUM 1.000% W/W LINSEED OIL BP 3.00% W/W MENTHOL IP 5.00% W/W METHYL SALICYLATE IP 10.00% W/W BENZYL ALCOHOL IP 1.0 % W/W GEL BASE Q.S. | |
220 | URSODEOXYCHOLIC ACID IP TABLETS 150 MG | EACH UNCOATED TABLET CONATINS URSODEOXYCHOLIC ACID IP 150 MG EXCIPIENTS Q.S. | IP |
221 | TRAZODONE HYDROCHLORIDE TABLETS BP | EACH UNCOATED TABLET CONTAINS TRAZODONE HYDROCHLORIDE BP 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | U.S.P |
222 | HALOPERIDOL TABLET IP | EACH UNCOATED TABLET CONTAINS HALOPERIDOL IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
223 | PRAMIPEXOLE TABLETS | EACH UNCOATED TABLET CONTAINS PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE BP 0.5 MG EXCIPIENTS Q.S. | |
224 | DULOXETINE GASTRO-RESISTANT TABLETS IP | EACH ENTERIC COATED TABLET CONATINS DULOXETINE HYDROCHLORIDE IP EQ TO DULOXETINE 40 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
225 | DICLOFENAC DIETHYLAMINE, LINSEED OIL, MENTHOL, METHYL SALICYLATE & BENZYL ALCOHOL GEL | COMPOSITION DICLOFENAC DIETHYLAMINE IP 2.30%W/W EQ TO DICLOFENAC SODIUM 2.00%W/W LINSEED OIL BP 3.00%W/W MENTHOL IP 5.0%W/W METHYL SALICYLATE IP 10.0%W/W BENZYL ALCOHOL IP 1.0% W/W GEL BASE Q.S. | |
226 | DEXTROMETHORPHAN TABLET 20 MG | EACH UNCOATED TABLET CONTAINS DEXTROMETHORPHAN HYDROBROMIDE IP 20 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
227 | DEXTROMETHORPHAN TABLET 30 MG | EACH UNCOATED TABLET CONTAINS DEXTROMETHORPHAN HYDROBROMIDE IP 30 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
228 | NEOMYCIN, BECLOMETHASONE , CLOTRIMAZOLE & LIGNOCAINE EAR DROPS | COMPOSITION BECLOMETHASONE DIPROPIONATE IP 0.025% W/V CLOTRIMAZOLE IP 1.0% W/V LIGNOCAINE HYDROCHLORIDE IP 2.0% W/V NEOMYCIN SULPHATE IP 0.5% W/V IN AQUES BASE SOLUTION Q.S. | |
229 | ISOTRETINOIN CAPSULES IP 20 MG | EACH HARD GELATIN CAPSULE CONTAINS ISOTRETINOIN IP 20 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY CAPSULE SHELLS | IP |
230 | OFLOXACIN TABLETS IP 200 MG | EACH FILM COATED TABLET CONTAINS OFLOXACIN IP 200 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
231 | PARACETAMOL & DROTAVERINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAIN DROTAVERINE HYDROCHLORIDE IP 80 MG PARACETAMOL IP 325 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
232 | DICLOFENAC DIETHYLAMINE, LINSEED OIL,MENTHOL , METHYL SALICYLATE & CAPSAICIN GEL | COMPOSITION DICLOFENAC DIETHYLAMINE IP 1.16% W/W EQ TO DICLOFENAC SODIUM 1.00% W/W LINSEED OIL BP 3.00% W/W MENTHOL IP 5.00% W/W METHYL SALICYLATE IP 10.00% W/W CAPSAICIN USP 0.025%W/W GEL BASE Q.S. | |
233 | AMLODIPINE & TELMISARTAN TABLETS IP | EACH FILM COATED TABLET CONTAINS TELMISARTAN IP 40 MG AMLODIPINE BESYLATE IP EQ TO AMLODIPINE 5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
234 | LINEZOLID TABLETS IP | EACH UNCOATED TABLET CONTAINS LINEZOLID IP 600 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
235 | PARACETAMOL & CAFFEINE TABLETS IP | EACH UNCOATED TABLET CONTAINS PARACETAMOL IP 650 MG CAFFEINE ANHYDROUS IP 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
236 | DICLOFENAC SODIUM SR TABLETS IP | EACH FILM COATED SUSTAINED RELEASE TABLET CONTAINS DICLOFENC SODIUM IP 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
237 | HYDROXYZINE HYDROCHLORIDE TABLETS IP | EACH FILM COATED TABLET CONTAINS HYDROXYZINE HYDROCHLORIDE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
238 | SILDENAFIL CITRATE TABLETS BP (FOR EXPORT) | EACH FILM COATED TABLET CONTAINS SILDENAFIL CITRATE BP EQ.TO SILDENAFIL 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
239 | ATORVASTATIN TABLETS IP 10 MG | EACH FILM COATED TABLET CONTAINS ATORVASTATIN CALCIUM IP EQ TO ATORVASTATIN 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
240 | ROSUVASTATIN CALCIUM TABLETS IP | EACH FILM COATED TABLET. CONTAINS ROSUVASTATIN CALCIUM EQ.TO ROSUVASTATIN 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
241 | NORFLOXACIN TABLETS IP | EACH FILM COATED TABLET CONTAINS NORFLOXACIN IP 400 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
242 | NIMESULIDE TABLETS 100 MG | EACH UNCOATED TABLETS CONTAINS NIMESULIDE BP 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
243 | NORFLOXACIN & TINIDAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS NORFLOXACIN IP 400 MG TINIDAZOLE IP 600 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
244 | TADALAFIL TABLETS IP 20 MG | EACH FILM COATED TABLET CONTAINS TADALAFIL IP 20 MG EXCIPINTS Q.S. APPROVED COLOUR USED | IP |
245 | SILVER SULFADIAZINE, LIGNOCAINE HYDROCHLORIDE & CHLORHEXIDINE GLUCONATE CREAM | COMPOSITION SILVER SULFADIAZINE IP 1.00 % W/W LIGNOCAINE HYDROCHLORIDE IP 2.00 % W/W CHLORHEXIDINE GLUCONATE SOLUTION IP EQ. TO CHLORHEXIDINE GLUCONATE 0.20 % W/W CREAM BASE Q.S. | |
246 | DEXTROMETHORPHAN HYDROBROMIDE & CHLORPHENIRAMINE MALEATE SYRUP | EACH 5 ML CONTAINS DEXTROMETHORPHAN HYDROBROMIDE IP 10 MG CHLORPHENIRAMINE MALEATE IP 4 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED | |
247 | AMLODIPINE & LOSARTAN POTASSIUM TABLETS IP | EACH FILM COATED TABLET CONTAINS AMLODIPINE BESYLATE IP EQ TO AMLODIPINE 5 MG LOSARTAN POTASSIUM IP 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
248 | CHLORBUTOL, BENZOCAINE & PARADICHLOROBENZENE EAR DROPS | COMPOSITION CHLORBUTOL IP 5.00% W/V BENZOCAINE IP 2.50% W/V PARADICHLOROBENZENE 2.00% W/V NON AQUEOUS BASE Q.S. | |
249 | CETIRIZINE TABLETS BP (FOR EXPORT) | EACH FILM COATED TABLET CONTAINS CETIRIZINE DIHYDROCHLORIDE BP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
250 | MIRTAZAPINE TABLETS IP 15 MG | EACH FILM COATED TABLET CONTAINS MIRTAZAPINE IP 15 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
251 | ATORVASTATIN TABLETS IP | EACH FILM COATED TABLET CONTAINS ATORVASTATIN CALCIUM IP EQ TO ATORVASTATIN 20 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
252 | PARACETAMOL DROPS | EACH ML CONTAINS PARACETAMOL IP 150 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED | |
253 | BROMHEXINE HYDROCHLORIDE, GUAIPHENESIN & TERBUTALINE SULPHATE SYRUP | EACH 5 ML CONTAINS BROMHEXINE HYDROCHLORIDE IP 2.0 MG TERBUTALINE SULPHATE IP 2.5 MG GUAIPHENESIN IP 100 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED | |
254 | OMEPRAZOLE MAGNESIUM & DOMPERIDONE TABLETS | EACH ENTERIC COATED TABLET CONTAINS OMEPRAZOLE MAGNESIUM BP EQ TO OMEPRAZOLE 10 MG DOMPERIDONE IP 15 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
255 | OMEPRAZOLE MAGNESIUM & DOMPERIDONE TABLETS | EACH ENTERIC COATED TABLET CONTAINS OMEPRAZOLE MAGNESIUM BP EQ TO OMEPRAZOLE 10 MG DOMPERIDONE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
256 | THYMOL, MENTHOL, ICHTHAMMOL & LIGNOCAINE HCl OINTMENT | COMPOSITION THYMOL IP 0.50%W/W MENTHOL IP 1.0%W/W ICHTHAMMOL BP 0.20%W/W LIGNOCAINE HYDROCHLORIDE IP 1.00%W/W IN OINTMENT BASE Q.S. | |
257 | VENLAFAXINE HYDROCHLORIDE EXTENDED RELEASE TABLETS | EACH UNCOATED EXTENDED RELEASE TABLET CONTAINS VENLAFAXINE HYDROCHLORIDE IP EQ TO VENLAFAXINE 75 MG EXCIPIENTS Q.S. | |
258 | PHENYLEPHRINE HYDROCHLORIDE, PARACETAMOL & CHLORPHENIRAMINE MALEATE DROP | EACH ML CONTAINS PHENYLEPHRINE HYDROCHLORIDE IP 2.5 MG PARACETAMOL IP 125 MG CHLORPHENIRAMINE MALEATE IP 1 MG IN A FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED | |
259 | PRAZIQUANTEL TABLETS BP | EACH UNCOATED TABLET CONTAINS PRAZIQUANTEL BP 600 MG EXCIPIENTS Q.S. | U.S.P |
260 | ILAPRAZOLE & DOMPERIDONE CAPSULES | COMPOSITION EACH HARD GELATIN CAPSULE CONTAINS ILAPRAZOLE IP 10 MG (AS ENTERIC COATED PELLETS) DOMPERIDONE IP 30 MG (AS SUSTAINED RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS | |
261 | FEXOFENADINE HYDROCHLORIDE TABLETS IP 180 mg | EACH FILM COATED TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE IP 180 mg EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
262 | TERBUTALINE SULPHATE, BROMHEXINE HYDROCHLORIDE, GUAIPHENESIN & MENTHOL SYRUP | EACH 5 ML CONTAINS BROMHEXINE HYDROCHLORIDE IP 4 mg TERBUTALINE SULPHATE IP 2.50 mg GUAIPHENESIN IP 100 mg MENTHOL IP 0.5 mg FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED | |
263 | LEVOCETIRIZINE DIHYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS LEVOCETIRIZINE DIHYDROCHLORIDE IP 2.5 mg FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED | |
264 | ACECLOFENAC SUSTAINED RELEASE AND ENTERIC COATED RABEPRAZOLE SODIUM CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS ACECLOFENAC IP 200 MG (AS SUSTAINED RELEASE PELLETS ) RABEPRAZOLE SODIUM IP 20 MG (AS ENTERIC COATED PELLETS ) EXCIPIENTS Q.S. COLOUR APPROVED COLOUR USED | |
265 | ZONISAMIDE CAPSULES USP 100 MG | COMPOSITION EACH HARD GELATIN CAPSULE CONTAINS ZONISAMIDE IP 100 MG APPROVED COLOUR USED IN CAPSULE SHELLS. | |
266 | RABEPRAZOLE GASRTO-RESISTANT AND DOMPERIDONE SUSTAINED-RELEASE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS RABEPRAZOLE SODIUM IP 20 MG (AS ENTERIC COATED PELLETS) DOMPERIDONE IP 30 MG (AS SUSTAINED-RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED | |
267 | ESOMEPRAZOLE GASTRO-RESISTANT AND DOMPERIDONE SUSTAINED-RELEASE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS ESOMEPRAZOLE MAGNESIUM TRIHYDRATE IP EQUIVALENT TO ESOMEPRAZOLE 40 MG (AS ENTERIC COATED PELLETS) DOMPERIDONE IP 30 MG (AS SUSTAINED-RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED | |
268 | PANTOPRAZOLE (EC) & LEVOSULPIRIDE (SR) CAPSULES | EACH HARD GELATIN CAPSULES CONTAINS PANTOPRAZOLE SODIUM SESQUIHYDRATE IP EQUIVALENT TO PANTOPRAZOLE 40 MG (AS ENTERIC COATED PELLETS) LEVOSULPIRIDE 75 MG (AS SUSTAINED RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED | |
269 | RABEPRAZOLE SODIUM (EC) AND LEVOSULPIRIDE (SR) CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS RABEPRAZOLE SODIUM IP 20 MG (AS ENTERIC COATED PELLETS) LEVOSULPIRIDE 75 MG (AS SUSTAINED-RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED | |
270 | PARACETAMOL, PHENYLEPHRINE HCL, CHLORPHENIRAMINE MALEATE, SODIUM CITRATE AND MENTHOL SUSPENSION | EACH 5 ML CONTAINS - PARACETAMOL IP 250 MG PHENYLEPHRINE HYDROCHLORIDE IP 5 MG CHLORPHENIRAMINE MALEATE IP 2 MG SODIUM CITRATE IP 60 MG MENTHOL IP 1 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
271 | CYPROHEPTADINE HYDROCHLORIDE & TRICHOLINE CITRATE SYRUP | EACH 5 ML CONTAINS CYPROHEPTADINE HCL IP 2 MG TRICHOLINE CITRATE 275 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
272 | TERBUTALINE SULPHATE, GUAIPHENESIN, BROMHEXINE HCl &MENTHOL SYRUP | EACH 5 ML CONTAINS TERBUTALINE SULPHATE IP 1.25 MG GUAIPHENESIN IP 50 MG BROMHEXINE HCl IP 4 MG MENTHOL IP 2.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
273 | LEVOSALBUTAMOL SULPHATE, AMBROXOL HCL & GUAIPHENESIN SYRUP | EACH 5 ML CONTAINS LEVOSALBUTAMOL SULPHATE IP EQUIVALENT TO LEVOSALBUTAMOL 1 MG AMBROXOL HCL IP 30 MG GUAIPHENESIN IP 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
274 | PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE & CHLORPHENIRAMINE MALEATE TABLETS | EACH UNCOATED TABLETS CONTAINS PARACETAMOL IP 500 MG PHENYLEPHRINE HYDROCHLORIDE IP 10 MG CHLORPHENIRAMINE MALEATE IP 2 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
275 | AMBROXOL HYDROCHLORIDE, DEXTROMETHORPHAN HBr, CETIRIZINE & MENTHOL SYRUP | EACH 5 ML CONTAINS AMBROXOL HYDROCHLORIDE IP 15 MG DEXTROMETHORPHAN HBr IP 10 MG CETIRIZINE DIHYDROCHLORIDE IP 5 MG MENTHOL IP 0.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
276 | CALCIUM CITRATE, MAGNESIUM, ZINC & VITAMIN D3TABLETS | EACH FILM COATED TABLET CONTAINS - CALCIUM CITRATE USP 1000 MG MAGNESIUM HYDROXIDE IP EQUIVALENT TO ELEMENTAL MAGNESIUM 100 MG ZINC SULPHATE MONOHYDRATE IP EQUIVALENT TO ELEMENTEL ZINC 4 MG VITAMIN D3 IP 200 IU EXCIPIENTS Q.S APPROVED COLOUR USED | |
277 | DRIED ALUMINIUM HYDROXIDE GEL, MAGNESIUM HYDROXIDE AND SIMETHICONE SUSPENSION | EACH 5 ML CONTAINS DRIED ALUMINIUM HYDROXIDE GEL IP 250 MG MAGNESIUM HYDROXIDE IP 250 MG SIMETHICONE IP 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
278 | LEVOFLOXACIN & ORNIDAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS LEVOFLOXACIN HEMIHYDRATE IP EQUIVALENT TO LEVOFLOXACIN 250 MG ORNIDAZOLE IP 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
279 | MILK OF MAGNESIA LIQUID PARAFFIN AND SODIUM PICOSULFATE SUSPENSION | EACH 5ML CONTAINS - LIQUID PARAFFIN IP 1.25 ML MILK OF MAGNESIA IP 3.75 ML SODIUM PICOSULFATE BP 3.33 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
280 | PARACETAMOL & MEFENAMIC ACID SUSPENSION | EACH 5 ML CONTAINS - PARACETAMOL IP 250 MG MEFENAMIC ACID IP 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
281 | MEFENAMIC ACID & PARACETAMOL SUSPENSION | EACH 5ML CONTAINS - PARACETAMOL IP 125 MG MEFENAMIC ACID IP 50.0 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
282 | PARACETAMOL, CHLORPHENIRAMINE MALEATE AND PHENYLEPHRINE HYDROCHLORIDE SUSPENSION | EACH 5 ML CONTAINS PARACETAMOL IP 250 MG CHLORPHENIRAMINE MALEATE IP 2 MG PHENYLEPHRINE HCI IP 5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
283 | PHENYLEPHRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE SUSPENSION | EACH 5 ML CONTAINS PHENYLEPHRINE HYDROCHLORIDE IP 5 MG CHLORPHENIRAMINE MALEATE IP 2 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
284 | TRANEXAMIC ACID & MEFENAMIC ACID TABLETS | EACH FILM COATED TABLET CONTAINS TRANEXAMIC ACID IP 500 MG MEFENAMIC ACID IP 250 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
285 | PANTOPRAZOLE & DOMPERIDONE TABLETS | EACH ENTERIC COATED TABLET CONTAINS PANTOPRAZOLE SODIUM IP EQUIVALENT. TO PANTOPRAZOLE 20 MG DOMPERIDONE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
286 | AMBROXOL HYDROCHLORIDE, GUAIPHENESIN AND TERBUTALINE SULPHATE SYRUP | EACH 5 ML CONTAINS AMBROXOL HYDROCHLORIDE IP 15 MG GUAIPHENESIN IP 50 MG TERBUTALINE SULPHATE IP 1.25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
287 | MONTELUKAST SODIUM & LEVOCETIRIZINE HCL DISPERSIBLE TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS MONTELUKAST SODIUM IP EQUIVALENT TO MONTELUKAST 4 MG LEVOCETIRIZINE HYDROCHLORIDE IP 2.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
288 | AMBROXOL HYDROCHLORIDE, LEVOSALBUTAMOL AND GUAIPHENESIN SYRUP | EACH 5 ML CONTAINS AMBROXOL HYDROCHLORIDE IP 15 MG LEVOSALBUTAMOL SULPHATE IP EQUIVALENT TO LEVOSALBUTAMOL 0.5 MG GUAIPHENESIN IP 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
289 | DEXTROMETHORPHAN HBr, PHENYLEPHRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE SYRUP | EACH 5 ML CONTAINS DEXTROMETHORPHAN HYDROBROMIDE IP 15 MG CHLORPHENIRAMINE MALEATE IP 2 MG PHENYLEPHRINE HYDROCHLORIDE IP 5 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED | |
290 | ITRACONAZOLE CAPSULES B.P | EACH HARD GELATIN CAPSULE CONTAINS ITRACONAZOLE PELLETS EQUIVALENT TO ITRACONAZOLE BP 200 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN THE CAPSULE SHELLS | |
291 | OMEPRAZOLE GASTRO-RESISTANT AND DOMPERIDONE CAPSULES IP | EACH HARD GELATIN CAPSULE CONTAINS OMEPRAZOLE IP 20 MG (AS ENTERIC COATED PELLETS) DOMPERIDONE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
292 | SUCRALFATE & OXETACAINE SUSPENSION | EACH 5 ML CONTAINS SUCRALFATE IP 1 G OXETACAINE BP 20 MG FLAVOURED SYRUPY BASE Q.S. | |
293 | DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE SYRUP | EACH 5 ML CONTAINS DEXTROMETHORPHAN HYDROBROMIDE IP 10 MG PHENYLEPHRINE HYDROCHLORIDE IP 5 MG CHLORPHENIRAMINE MALEATE IP 2 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED | |
294 | PARACETAMOL, PHENYLEPHRINE HCL & CHLORPHENIRAMINE MALEATE SUSPENSION | EACH 5 ML CONTAINS PARACETAMOL IP 125 MG PHENYLEPHRINE HCL IP 2.5 MG CHLORPHENIRAMINE MALEATE IP 1 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED | |
295 | PARACETAMOL ORAL SUSPENSION IP | EACH 5 ML CONTAINS PARACETAMOL IP 250 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED | |
296 | PANTOPRAZOLE GASTRO-RESISTANT TABLETS IP | EACH ENTERIC COATED TABLET CONTAINS PANTOPRAZOLE SODIUM IP EQ. TO PANTOPRAZOLE 40 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
297 | LEVOCETIRIZINE DIHYDROCHLORIDE WITH MONTELUKAST SODIUM SYRUP | EACH 5 ML CONTAINS LEVOCETIRIZINE DIHYDROCHLORIDE 2.5 MG MONTELUKAST SODIUM IP EQ. TO MONTELUKAST 4 MG IN A FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED | |
298 | AMBROXOL HCL, TERBUTALINE, GUAIPHENESIN AND MENTHOL SYRUP | EACH 5 ML CONTAINS AMBROXOL HYDROCHLORIDE 15 MG TERBUTALINE SULPHATE IP 1.25 MG GUAIPHENESIN IP 50 MG MENTHOL IP 2.5 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED | |
299 | ONDANSETRON ORAL SOLUTION IP | EACH 5 ML CONTAINS ONDANSETRON HYDROCHLORIDE IP EQUIVALENT TO ONDANSETRON 2 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
300 | ACECLOFENAC & PARACETAMOL TABLETS 100/325 MG | EACH UNCOATED BILAYERED TABLET CONTAINS ACECLOFENAC IP 100 MG PARACETAMOL IP 325 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
301 | RABEPRAZOLE GASTRO-RESISTANT TABLETS IP | EACH ENTERIC COATED TABLET CONTAINS RABEPRAZOLE SODIUM IP 20 MG EXCEIPIENTS Q.S. APPROVED COLOUR USED | |
302 | DOXYLAMINE SUCCINATE 10 MG, PYRIDOXINE HYDROCHLORIDE 10 MG & FOLIC ACID 2.5 MG TABLETS | EACH ENTERIC COATED TABLET CONTAINS DOXYLAMINE SUCCINATE BP 10 MG PYRIDOXINE HYDROCHLORIDE IP 10 MG FOLIC ACID IP 2.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
303 | LACTULOSE SOLUTION USP | EACH 15 ML CONTAINS LACTULOSE SOLUTION BP EQUIVALENT TO LACTULOSE 10 GM FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED | USP |
304 | FERROUS ASCORBATE & FOLIC ACID SYRUP | EACH 5 ML CONTAINS FERROUS ASCORBATE EQUIVALENT TO ELEMENTAL IRON 30 MG FOLIC ACID IP 550 MCG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED | |
305 | CALCIUM CARBONATE & VITAMIN D3 TABLETS | EACH FILM-COATED TABLET CONTAINS CALCIUM CARBONATE IP 1250 MG (FROM AN ORGANIC SOURCE OYSTER SHELL) EQUIVALENT TO ELEMENTAL CALCIUM 500 MG VITAMIN D3 IP 250 IU EXCIPIENTS Q.S. APPROVED COLOUR USED | |
306 | CALCIUM CITRATE, VITAMIN D3, MAGNESIUM & ZINC TABLETS | EACH FILM-COATED TABLET CONTAINS CALCIUM CITRATE USP 1000 MG MAGNESIUM HYDROXIDE IP EQUIVALENT TO ELEMENTAL MAGNESIUM 100 MG ZINC SULPHATE MONOHYDRATE IP EQUIVALENT TO ELEMENTAL ZINC 4 MG VITAMIN D3 IP 1000 IU EXCIPIENTS Q.S. APPROVED COLOUR USED | |
307 | CALCIUM CITRATE, CALCITRIOL & ZINC TABLETS | EACH FILM-COATED TABLET CONTAINS CALCIUM CITRATE USP 1000 MG CALCITRIOL IP 0.25 MG ZINC SULPHATE MONOHYDRATE IP EQUIVALENT TO ELEMENTAL ZINC 4 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
308 | DEFLAZACORT TABLETS | EACH UNCOATED TABLET CONTAINS DEFLAZACORT 30 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
309 | FEXOFENADINE HYDROCHLORIDE & MONTELUKAST TABLETS | EACH FILM-COATED TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE IP 180 MG MONTELUKAST SODIUM IP EQUIVALENT TO MONTELUKAST 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
310 | METFORMIN PROLONGED RELEASE AND GLIMEPIRIDE TABLETS IP | EACH UNCOATED BILAYERED TABLET CONTAINS GLIMEPIRIDE IP 2 MG METFORMIN HCL IP 500 MG (IN PROLONGED-RELEASE FROM) EXCIPIENTS Q.S. APPROVED COLOUR USED | |
311 | PIRACETAM TABLETS | EACH FILM COATED TABLET CONTAINS PIRACETAM IP 800 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
312 | RABEPRAZOLE SODIUM & DOMPERIDONE TABLETS | EACH ENTERIC-COATED TABLET CONTAINS RABEPRAZOLE SODIUM IP 20 MG DOMPERIDONE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
313 | ITRACONAZOLE CAPSULES BP | EACH HARD GELATIN CAPSULE CONTAINS ITRACONAZOLE PELLETS EQUIVALENT TO ITRACONAZOLE BP 200 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN THE CAPSULE SHELLS | |
314 | OXCARBAMEZEPINE TABLETS IP 600 MG | EACH FILM -COATED TABLET CONTAINS OXCARBAMAZEPINE IP 600 MG EXCIPENTS Q.S. APPROVED COLOUR USED | |
315 | DEFLAZACORT TABLETS | EACH UNCOATED TABLET CONTAINS DEFLAZACORT 6 MG EXCIPIENTS Q.S. | |
316 | CLOTRIMAZOLE VAGINAL TABLETS IP | EACH UNCOATED TABLET CONTAINS CLOTRIMAZOLE IP 100 MG EXCIPIENTS Q.S. | IP |
317 | DICLOFENAC DIETHYLAMINE, MENTHOL, METHYL SALICYLATE, LINSEED OIL & THIOCOLCHICOSIDE GEL | COMPOSITION DICLOFENAC DIETHYLAMINE IP 1.16% W/W EQ. TO DICLOFENAC SODIUM 1.00% W/W MENTHOL IP 5.00% W/W METHYL SALICYLATE IP 10.00% W/W LINSEED OIL BP 3.00% W/W THIOCOLCHICOSIDE IP 0.125% W/W GEL BASE Q.S. | |
318 | ITRACONAZOLE CAPSULES BP | EACH HARD GELATIN CAPSULE CONTAINS ITRACONAZOLE PELLETS EQUIVALENT TO ITRACONAZOLE BP 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN THE CAPSULE SHELLS | |
319 | METHYLDOPA TABLETS IP 500 MG | EACH FILM COATED TABLET CONTAINS METHYLDOPA IP EQUIVALENT TO ANHYDROUS METHYLDOPA 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
320 | METHYLDOPA TABLETS IP 250 MG | EACH FILM COATED TABLET CONTAINS METHYLDOPA IP EQUIVALENT TO ANHYDROUS METHYLDOPA 250 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
321 | DEFLAZACORT TABLETS | EACH UNCOATED TABLET CONTAINS DEFLAZACORT 1 MG EXCIPIENTS Q.S. | |
322 | LOPERAMIDE CAPSULES IP 2 MG | EACH HARD GELATIN CAPSULE CONTAINS LOPERAMIDE HYDROCHLORIDE IP 2 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY CAPSULE SHELLS | IP |
323 | LOPERAMIDE HYDROCHLORIDE TABLETS IP | EACH UNCOATED TABLET CONTAINS LOPERAMIDE HYDROCHLORIDE IP 2 MG EXCIPIENTS Q.S. | IP |
324 | CETIRIZINE TABLETS IP | EACH FILM COATED TABLET CONTAINS CETIRIZINE DIHYDROCHLORIDE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
325 | CALCIUM CARBONATE & VITAMIN D3 TABLETS | EACH FILM-COATED TABLET CONTAINS CALCIUM CARBONATE IP 1250 MG (FROM AN ORGANIC SOURCE OYSTER SHELL) EQUIVALENT TO ELEMENTAL CALCIUM 500 MG VITAMIN D3 IP 500 IU EXCIPIENTS Q.S. APPROVED COLOUR USED | |
326 | TADALAFIL TABLETS IP 10 MG | EACH FILM COATED TABLET CONTAINS TADALAFIL IP 10 MG EXCIPINTS Q.S. APPROVED COLOUR USED | IP |
327 | TERBUTALINE SULPHATE, BROMHEXINE HYDROCHLORIDE, GUAIPHENESIN TABLETS | EACH UNCOATED TABLET CONTAINS BROMHEXINE HYDROCHLORIDE IP 4 MG TERBUTALINE SULPHATE IP 2.5 MG GUAIPHENESIN IP 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
328 | BROMOCRIPTINE MESYLATE TABLETS IP | EACH UNCOATED TABLET CONTAINS BROMOCRIPTINE MESYLATE IP 2.87 MG EQ. TO BROMOCRIPTINE 2.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
329 | TRANEXAMIC ACID TABLETS IP | EACH FILM COATED TABLET CONTAINS TRANEXAMIC ACID IP 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
330 | DRIED ALUMINIUM HYDROXIDE GEL, MAGNESIUM HYDROXIDE AND SIMETHICONE SUSPENSION | EACH 5 ML CONTAINS DRIED ALUMINIUM HYDROXIDE GEL IP 200 MG MAGNESIUM HYDROXIDE IP 200 MG SIMETHICONE IP 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
331 | SILDENAFIL CITRATE TABLETS IP 50 MG | EACH FILM COATED TABLET CONTAINS SILDENAFIL CITRATE IP EQ.TO SILDENAFIL 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
332 | PARACETAMOL TABLETS IP 650 MG | EACH UNCOATED TABLET CONTAINS PARACETAMOL IP 650 MG EXCIPIENTS Q.S. | IP |
333 | NIMESULIDE & PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS NIMESULIDE BP 100 MG PARACETAMOL IP 325 MG EXCIPIENTS Q.S. NOT FOR USE BELOW 12 YEARS OF AGE | |
334 | ACECLOFENAC & PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS ACECLOFENAC IP 100 MG PARACETAMOL IP 325 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
335 | CETIRIZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE AND PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS CETIRIZINE HYDROCHLORIDE IP 5 MG PHENYLEPHRINE HYDROCHLORIDE IP 5 MG PARACETAMOL IP 325 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
336 | ACECLOFENAC & PARACETAMOL TABLETS | EACH FILM COATED TABLET CONTAINS ACECLOFENAC IP 100 MG PARACETAMOL IP 325 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
337 | ACECLOFENAC, PARACETAMOL & CHLORZOXAZONE TABLETS | EACH UNCOATED TABLET CONTAINS ACECLOFENAC IP 100 MG PARACETAMOL IP 325 MG CHLORZOXAZONE USP 250 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
338 | DICLOFENAC POTASSIUM, PARACETAMOL AND CHLORZOXAZONE TABLETS | EACH UNCOATED TABLET CONTAINS DICLOFENAC POTASSIUM IP 50 MG PARACETAMOL IP 325 MG CHLORZOXAZONE USP 250 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
339 | GLIMEPIRIDE AND METFORMIN HCl SUSTAINED RELEASE TABLETS | EACH UNCOATED BILAYERED TABLET CONTAINS GLIMEPIRIDE IP 2 MG METFORMIN HCl IP 500 MG (IN SUSTAINED RELEASE FORM) EXCIPIENTS Q.S. APPROVED COLOUR USED | |
340 | ONDANSETRON ORALLY DISINTEGRATING TABLETS IP | EACH UNCOATED ORALLY DISINTEGRATING TABLET CONTAINS ONDANSETRON HYDROCHLORIDE IP EQ. TO ONDANSETRON 4 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
341 | METFORMIN HYDROCHLORIDE TABLETS IP | EACH UNCOATED TABLET CONTAINS METFORMIN HYDROCHLORIDE IP 500 MG EXCIPIENTS Q.S. | IP |
342 | METFORMIN HYDROCHLORIDE TABLETS IP | EACH FILM COATED TABLET CONTAINS METFORMIN HYDROCHLORIDE IP 850 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
343 | GLIMEPIRIDE AND METFORMIN HCl SUSTAINED RELEASE TABLETS | EACH UNCOATED BILAYERED TABLET CONTAINS GLIMEPIRIDE IP 1 MG METFORMIN HYDROCHLORIDE IP 500 MG (IN SUSTAINED RELEASE FORM) EXCIPIENTS Q.S. APPROVED COLOUR USED | |
344 | ONDANSETRON ORALLY DISINTEGRATING TABLETS | EACH UNCOATED ORALLY DISINTEGRATING TABLET CONTAINS ONDANSETRON HYDROCHLORIDE IP EQ. TO ONDANSETRON 2 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
345 | TENELIGLIPTIN AND METFORMIN HYDROCHLORIDE PROLONGED RELEASE TABLETS IP | EACH UNCOATED BILAYER TABLET CONTAINS TENELIGLIPTIN HYDROBROMIDE HYDRATE IP EQ. TO TENELIGLIPTIN 20 MG METFORMIN HYDROCHLORIDE IP 500 MG (PROLONGED RELEASE FORM) EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
346 | DICLOFENAC SODIUM & PARACETAMOL TABLETS IP | EACH UNCOATED TABLET CONTAINS DICLOFENAC SODIUM IP 50 MG PARACETAMOL IP 325 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
347 | TENELIGLIPTIN 20 MG AND METFORMIN HYDROCHLORIDE (SR) 1000 MG TABLETS IP | EACH UNCOATED BILAYER TABLET CONTAINS TENELIGLIPTIN HYDROBROMIDE HYDRATE IP EQ. TO TENELIGLIPTIN 20 MG METFORMIN HYDROCHLORIDE IP 1000 MG (IN SUSTAINED RELEASE FORM) EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
348 | TENELIGLIPTIN 20 MG AND METFORMIN HYDROCHLORIDE (SR) 850 MG TABLETS | EACH UNCOATED BILAYER TABLET CONTAINS TENELIGLIPTIN HYDROBROMIDE HYDRATE IP EQ. TO TENELIGLIPTIN 20 MG METFORMIN HYDROCHLORIDE IP 850 MG (IN SUSTAINED RELEASE FORM) EXCIPIENTS Q.S. APPROVED COLOUR USED | |
349 | CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE & MENTHOL SYRUP | EACH 5 ML CONTAINS DEXTROMETHORPHAN HYDROBROMIDE IP 10 MG PHENYLEPHRINE HYDROCHLORIDE IP 5 MG CHLORPHENIRAMINE MALEATE IP 2 MG MENTHOL IP 1.5 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED | |
350 | RABEPRAZOLE GASRTO-RESISTANT AND DOMPERIDONE SUSTAINED-RELEASE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS RABEPRAZOLE SODIUM IP 20 MG (AS ENTERIC COATED PELLETS) DOMPERIDONE IP 30 MG (AS SUSTAINED-RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY CAPSULES SHELL AND PELLETS | |
351 | ESOMEPRAZOLE GASTRO-RESISTANT AND DOMPERIDONE SUSTAINED-RELEASE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS ESOMEPRAZOLE MAGNESIUM TRIHYDRATE IP EQ. TO ESOMEPRAZOLE 40 MG (AS ENTERIC COATED PELLETS) DOMPERIDONE IP 30 MG (AS SUSTAINED-RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY CAPSULES SHELL AND PELLETS | |
352 | PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE & CETIRIZINE DI-HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS PARACETAMOL IP 325 MG PHENYLEPHRINE HYDROCHLORIDE IP 5 MG CETIRIZINE DI- HYDROCHLORIDE IP 5 MG EXCPIENTS Q.S. APPROVED COLOUR USED | |
353 | GLIMEPIRIDE, PIOGLITAZONE AND METFORMIN HCl SUSTAINED RELEASE TABLETS | EACH UNCOATED BILAYER TABLET CONTAINS GLIMEPIRIDE IP 2 MG PIOGLITAZONE HYDROCHLORIDE IP EQ. TO PIOGLITAZONE 15 MG METFORMIN HYDROCHLORIDE IP 500 MG (IN SUSTAINED RELEASE FORM) EXCIPIENTS Q.S. APPROVED COLOUR USED | |
354 | GLIMEPIRIDE, PIOGLITAZONE AND METFORMIN HCl SUSTAINED RELEASE TABLETS | EACH UNCOATED BILAYER TABLET CONTAINS GLIMEPIRIDE IP 1 MG PIOGLITAZONE HYDROCHLORIDE IP EQ. TO PIOGLITAZONE 15 MG METFORMIN HYDROCHLORIDE IP 500 MG (IN SUSTAINED RELEASE FORM) EXCIPIENTS Q.S. APPROVED COLOUR USED | |
355 | GLIMEPIRIDE TABLETS IP 1 MG | EACH UNCOATED TABLET CONTAINS GLIMEPIRIDE IP 1 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
356 | PANTOPRAZOLE GASTRO-RESISTANT AND DOMPERIDONE PROLONGED-RELEASE CAPSULES IP | EACH HARD GELATIN CAPSULE CONTAINS PANTOPRAZOLE SODIUM SESQUIHYDRATE IP EQ. TO PANTOPRAZOLE 40 MG (AS ENTERIC COATED PELLETS) DOMPERIDONE IP 30 MG (AS PROLONGED-RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL AND PELLETS | IP |
357 | PARACETAMOL PAEDIATRIC ORAL SUSPENSION IP | EACH 5 ML CONTAINS PARACETAMOL IP 125 MG EXCIPIENTS Q.S APPROVED COLOUR USED | IP |
358 | LEVOFLOXACIN TABLETS IP | EACH FILM COATED TABLET CONTAINS LEVOFLOXACIN HEMIHYDRATE IP EQ. TO LEVOFLOXACIN 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
359 | ACECLOFENAC & THIOCOLCHICOSIDE TABLETS | EACH FILM COATED TABLET CONTAINS ACECLOFENAC IP 100 MG THIOCOLCHICOSIDE IP 4 MG EXCIPIENTS Q.S APPROVED COLOUR USED | |
360 | OFLOXACIN AND ORNIDAZOLE TABLETS IP | EACH FILM COATED TABLET CONTAINS: OFLOXACIN IP 200 MG ORNIDAZOLE IP 500 MG EXCIPIENTS Q.S APPROVED COLOUR USED | |
361 | PANTOPRAZOLE & DOMPERIDONE TABLETS | EACH ENTERIC COATED TABLET CONTAINS PANTOPRAZOLE SODIUM IP EQ. TO PANTOPRAZOLE 40 MG DOMPERIDONE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
362 | DISODIUM HYDROGEN CITRATE SYRUP | EACH 5 ML CONTAINS: DISODIUM HYDROGEN CITRATE BP 1.53 GM FLAVOURED BASE Q.S. APPROVED COLOUR USED | |
363 | ENTECAVIR TABLETS IP 1 MG | EACH FILM COATED TABLET CONTAINS ENTECAVIR IP 1 MG EXCIPIENTS Q.S APPROVED COLOUR USED | |
364 | ENTECAVIR TABLETS IP 0.5 MG | EACH FILM COATED TABLET CONTAINS ENTECAVIR IP 0.5 MG EXCIPIENTS Q.S APPROVED COLOUR USED | |
365 | OMEPRAZOLE GASTRO-RESISTANT CAPSULES IP | EACH HARD GELATIN CAPSULE CONTAINS OMEPRAZOLE IP 20 MG (AS ENTERIC COATED PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL & PELLETS. | |
366 | TERBINAFINE TABLETS IP 250 MG | EACH UNCOATED TABLET CONTAINS TERBINAFINE HYDROCHLORIDE IP EQ. TO TERBINAFINE 250 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
367 | TERBINAFINE TABLETS 500 MG | EACH UNCOATED TABLET CONTAINS TERBINAFINE HYDROCHLORIDE IP EQ. TO TERBINAFINE 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
368 | DROTAVERINE HYDROCHLORIDE & MEFENAMIC ACID TABLETS | EACH UNCOATED TABLET CONTAINS: DROTAVERINE HYDROCHLORIDE IP 80 MG MEFENAMIC ACID IP 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
369 | FEXOFENADINE HYDROCHLORIDE TABLETS IP 120 MG | EACH FILM COATED TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE IP 120 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
370 | POVIDONE-IODINE OINTMENT USP | CONTAINS: POVIDONE-IODINE IP 10% W/W (AVAILABLE IODINE 1.0% W/W) WATER-SOLUBLE OINTMENT BASE Q.S. | USP |
371 | FEXOFENADINE HYDROCHLORIDE & MONTELUKAST TABLETS | EACH FILM-COATED TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE IP 120 MG MONTELUKAST SODIUM IP EQ. TO MONTELUKAST 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
372 | DICLOFENAC SODIUM & PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS DICLOFENAC SODIUM IP 50 MG PARACETAMOL IP 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
373 | ITRACONAZOLE CREAM 1% W/W | COMPOSITION ITRACONAZOLE BP 1.00% W/W METHYL PARABEN IP 0.10% W/W PROPYL PARABEN IP 0.025% W/W CREAM BASE Q.S. | |
374 | POVIDONE-IODINE OINTMENT USP | CONTAINS: POVIDONE-IODINE IP 5 % W/W (AVAILABLE IODINE 1.0% W/W) WATER-SOLUBLE OINTMENT BASE Q.S. | USP |
375 | ETORICOXIB & PARACETAMOL TABLETS | EACH FILM COATED TABLET CONTAINS ETORICOXIB IP 60 MG PARACETAMOL IP 325 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
376 | PARACETAMOL & MEFENAMIC ACID TABLETS | EACH UNCOATED TABLET CONTAINS PARACETAMOL IP 325 MG MEFENAMIC ACID IP 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
377 | OMEPRAZOLE GASTRO-RESISTANT AND DOMPERIDONE CAPSULES IP | EACH HARD GELATIN CAPSULE CONTAINS OMEPRAZOLE IP 20 MG (AS ENTERIC COATED PELLETS) DOMPERIDONE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL & PELLETS. | IP |
378 | PANTOPRAZOLE & DOMPERIDONE TABLETS | EACH ENTERIC COATED TABLET CONTAINS PANTOPRAZOLE SODIUM IP EQ. TO PANTOPRAZOLE 40 MG DOMPERIDONE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
379 | PARACETAMOL & IBUPROFEN SUSPENSION | EACH 5 ML CONTAINS IBUPROFEN IP 100 MG PARACETAMOL IP 162.50 MG FLAVOURED SYRUP BASE Q.S. APPROVED COLOUR USED | |
380 | MONTELUKAST SODIUM & LEVOCETIRIZINE HCL TABLETS | EACH FILM COATED TABLET CONTAINS MONTELUKAST SODIUM IP EQUIVALENT TO MONTELUKAST 4 MG LEVOCETIRIZINE HYDROCHLORIDE IP 2.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
381 | KETOCONAZOLE TABLETS IP 200 MG | EACH UNCOATED TABLET CONTAINS: KETOCONAZOLE IP 200 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
382 | DICYCLOMINE HYDROCHLORIDE & PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS DICYCLOMINE HYDROCHLORIDE IP 20 MG PARACETAMOL IP 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
383 | PROCHLORPERAZINE MALEATE MOUTH DISSOLVING TABLET | EACH MOUTH DISSOLVING UNCOATED TABLET CONTAINS PROCHLORPERAZINE MALEATE IP 5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
384 | OXCARBAZEPINE TABLETS IP 300 MG | EACH FILM -COATED TABLET CONTAINS OXCARBAZEPIN IP 300 MG EXCIPENTS Q.S. APPROVED COLOUR USED | IP |
385 | GABAPENTIN TABLETS IP | EACH FILM COATED TABLET CONTAINS GABAPENTIN IP 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
386 | GABAPENTIN TABLETS IP | EACH FILM COATED TABLET CONTAINS: GABAPENTIN IP 300 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
387 | PIRFENIDONE TABLETS IP 200 MG | EACH FILM COATED TABLET CONTAINS: PIRFENIDONE IP 200 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
388 | TICAGRELOR TABLETS IP 90 MG | EACH FILM COATED TABLET CONTAINS: TICAGRELOR IP 90 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
389 | DAPAGLIFLOZIN TABLETS 10 MG | EACH FILM COATED TABLET CONTAINS: DAPAGLIFLOZIN 200 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
390 | TORSEMIDE TABLETS IP 20 MG | EACH UNCOATED TABLET CONTAINS: TORSEMIDE IP 20 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
391 | SITAGLIPTIN PHOSPHATE TABLETS IP | EACH FILM COATED TABLET CONTAINS: SITAGLIPTIN PHOSPHATE MONOHYDRATE IP EQ. TO SITAGLIPTIN 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
392 | SITAGLIPTIN PHOSPHATE TABLETS IP | EACH FILM COATED TABLET CONTAINS: SITAGLIPTIN PHOSPHATE MONOHYDRATE IP EQ. TO SITAGLIPTIN 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
393 | GLICLAZIDE EXTENDED RELEASE TABLETS 60 MG | EACH UNCOATED EXTENDED RELEASE TABLET CONTAINS GLICLAZIDE IP 60 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
394 | GLICLAZIDE EXTENDED RELEASE TABLETS 120 MG | EACH UNCOATED EXTENDED RELEASE TABLET CONTAINS GLICLAZIDE IP 120 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
395 | GLICLAZIDE TABLETS IP 80 MG | EACH UNCOATED TABLET CONTAINS GLICLAZIDE IP 80 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | IP |
396 | METOPROLOL SUCCINATE PROLONGED-RELEASE AND AMLODIPINE TABLETS IP | EACH UNCOATED BILAYERED TABLET CONTAINS METOPROLOL SUCCINATE IP 47.5 MG EQ. TO METOPROLOL TARTRATE 50 MG (AS PROLONGED-RELEASE) AMLODIPINE BESILATE IP EQ. TO AMLODIPINE 5 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP | IP |
397 | TELMISARTAN AND METOPROLOL SUCCINATE PROLONGED-RELEASE TABLETS | EACH UNCOATED BILAYERED TABLET CONTAINS TELMISARTAN IP 40 MG METOPROLOL SUCCINATE IP 47.5 MG EQ. TO METOPROLOL TARTRATE 50 MG (AS PROLONGED-RELEASE) EXCIPIENTS Q.S. COLOUR: QUINOLINE YELLOW | |
398 | METOPROLOL SUCCINATE PROLONGED-RELEASE AND AMLODIPINE TABLETS IP | EACH FILM COATED BILAYERED TABLET CONTAINS METOPROLOL SUCCINATE IP 47.5 MG EQ. TO METOPROLOL TARTRATE 50 MG (AS PROLONGED-RELEASE) AMLODIPINE BESILATE IP EQ. TO AMLODIPINE 5 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP | IP |
399 | ROSUVASTATIN, ASPIRIN AND CLOPIDOGREL CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS ROSUVASTATIN CALCIUM IP EQ. TO ROSUVASTATIN 10 MG CLOPIDOGREL BISULPHATE IP EQ. TO CLOPIDOGREL 75 MG ASPIRIN IP 75 MG (AS ENTERIC COATED) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL. | |
400 | ROSUVASTATIN, ASPIRIN AND CLOPIDOGREL CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS ROSUVASTATIN CALCIUM IP EQ. TO ROSUVASTATIN 20 MG CLOPIDOGREL BISULPHATE IP EQ. TO CLOPIDOGREL 75 MG ASPIRIN IP 75 MG (AS ENTERIC COATED) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL. | |
401 | FLUOXETINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS FLUOXETINE HYDROCHLORIDE IP EQ. TO FLUOXETINE 40 MG EXCIPIENTS Q.S. COLOUR: PONCEAU 4 R | |
402 | ZONISAMIDE TABLETS 100 MG | EACH FILM COATED TABLET CONTAINS ZONISAMIDE IP 100 MG COLOUR: TITANIUM DIOXIDE IP | |
403 | CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE & MENTHOL SYRUP | EACH 5 ML CONTAINS DEXTROMETHORPHAN HBr IP 10 MG PHENYLEPHRINE HYDROCHLORIDE IP 5 MG CHLORPHENIRAMINE MALEATE IP 2 MG MENTHOL IP 1.5 MG FLAVOURED SYRUPY BASE Q.S. COLOUR: PONCEAU 4 R | |
405 | GABAPENTIN & NORTRIPTYLINE HCL TABLETS | EACH FILM COATED TABLET CONTAINS GABAPENTIN IP 400 MG NORTRIPTYLINE HYDROCHLORIDE IP EQ. TO NORTRIPTYLINE 10 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP | |
406 | TAMSULOSIN HYDROCHLORIDE (MODIFIED RELEASE) DUTASTERIDE TABLETS | EACH FILM COATED TABLET CONTAINS TAMSULOSIN HYDROCHLORIDE IP 0.4 MG (AS MODIFIED RELEASE) DUTASTERIDE IP 0.5 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP | |
407 | CHLORAMPHENICOL, BENZOCAINE AND PROPYLENE GLYCOL EAR DROPS | COMPOSITION EACH ML CONTAINS CHLORAMPHENICOL IP 5% W/V BENZOCAINE IP 1% W/V PROPYLENE GLYCOL IP Q.S. (AS BASE) | |
408 | SUCRALFATE & OXETACAINE SUSPENSION | EACH 10 ML CONTAINS SUCRALFATE IP 1 G OXETACAINE BP 20 MG FLAVOURED SYRUPY BASE Q.S. COLOUR: SUNSET YELLOW | |
409 | DUTASTERIDE TABLETS 0.5 MG | EACH FILM COATED TABLET CONTAINS DUTASTERIDE IP 0.5 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP | |
410 | DROTAVERINE HYDROCHLORIDE & MEFENAMIC ACID TABLETS | EACH UNCOATED TABLET CONTAINS DROTAVERINE HYDROCHLORIDE IP 80 MG MEFENAMIC ACID IP 250 MG EXCIPIENTS Q.S. COLOUR: ERYTHROSINE | |
411 | POVIDONE IODINE OINTMENT USP | COMPOSITION POVIDONE IODINE IP 5% W/W (0.5%W/W AVAILABLE IODINE) OINTMENT BASE Q.S. | USP |
412 | DRIED ALUMINIUM HYDROXIDE, MAGNESIUM HYDROXIDE & OXETACAINE SUSPENSION | EACH 5 ML CONTAINS DRIED ALUMINIUM HYDROXIDE IP 0.291 G MAGNESIUM HYDROXIDE IP 98 MG OXETACAINE BP 10 MG EXCIPIENTS Q.S. COLOUR: ERYTHROSINE | |
413 | HYDROXYZINE HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS HYDROXYZINE HYDROCHLORIDE IP 10 MG FLAVOURED SYRUPY BASE COLOUR: YELLOW OXIDE OF IRON | |
414 | RIFAXIMIN TABLETS | EACH FILM COATED TABLET CONTAINS RIFAXIMIN BP 400 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
415 | LEVETIRACETAM TABLETS IP | EACH FILM COATED TABLET CONTAINS LEVETIRACETAM IP 750 MG EXCIPIENTS Q.S. COLOUR: FERRIC OXIDE OF YELLOW & TITANIUM DIOXIDE IP | IP |
416 | BILASTINE TABLETS | EACH UNCOATED TABLET CONTAINS BILASTINE 20 MG EXCIPIENTS Q.S. | |
417 | DICLOFENAC POTASSIUM & PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS DICLOFENAC POTASSIUM IP 50 MG PARACETAMOL IP 325 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
418 | AMBROXOL HCL, TERBUTALINE, GUAIPHENESIN AND MENTHOL SYRUP | EACH 5 ML CONTAINS AMBROXOL HYDROCHLORIDE IP 15 MG TERBUTALINE SULPHATE IP 1.25 MG GUAIPHENESIN IP 50 MG MENTHOL IP 2.5 MG FLAVOURED SYRUPY BASE Q.S. COLOUR: SUNSET YELLOW | |
419 | CETIRIZINE TABLETS | EACH FILM COATED TABLET CONTAINS CETIRIZINE DIHYDROCHLORIDE IP 5 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP | |
420 | LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS IP | EACH FILM COATED TABLET CONTAINS LEVOCETIRIZINE DIHYDROCHLORIDE IP 10 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP | IP |
421 | CALCIUM CARBONATE & VITAMIN D3 TABLETS | EACH FILM-COATED TABLET CONTAINS CALCIUM CARBONATE IP 1250 MG (FROM AN ORGANIC SOURCE OYSTER SHELL) EQUIVALENT TO ELEMENTAL CALCIUM 500 MG VITAMIN D3 IP 500 IU EXCIPIENTS Q.S. COLOUR: BRILLIANT BLUE & TITANIUM DIOXIDE IP | |
422 | METFORMIN HYDROCHLORIDE PROLONGED RELEASE TABLETS IP 500 MG | EACH UNCOATED PROLONGED RELEASE TABLETS CONTAINES METFORMIN HYDROCHLORIDE IP 500 MG EXCIPIENTS Q.S. | IP |
423 | METFORMIN HYDROCHLORIDE PROLONGED RELEASE TABLETS IP 1000 MG | EACH UNCOATED PROLONGED RELEASE TABLETS CONTAINES METFORMIN HYDROCHLORIDE IP 1000 MG EXCIPIENTS Q.S. | IP |
424 | PARACETAMOL, CHLORPHENAMINE MALEATE AND PHENYLEPHRINE HCL TABLETS | EACH UNCOATED TABLETS CONTAINES: PARACETAMOL IP 325 MG CHLORPHENAMINE MALEATE IP 2 MG PHENYLEPHRINE HCL IP 10 MG EXCIPIENTS Q.S. | |
425 | CITICOLINE TABLETS IP | EACH FILM COATED TABLETS CONTAINES CITICOLINE SODIUM IP EQUIVALENT TO CITICOLINE 500 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP | IP |
426 | ORLISTAT CAPSULES USP 120 MG | EACH HARD GELATIN CAPSULE CONTAINS ORLISTAT USP 120 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY CAPSULES SHELLS | USP |
427 | PARACETAMOL, PHENYLEPHRINE HCl, CAFFEINE AND DIPHENHYDRAMINE HCl TABLETS | EACH UNCOATED TABLET CONTAINS PARACETAMOL IP 325 MG PHENYLEPHRINE Hcl IP 5 MG CAFFEINE (ANHYDROUS) IP 30 MG DIPHENHYDRAMINE Hcl IP 25 MG EXCIPIENTS Q.S. | |
428 | FLUPENTIXOL AND MELITRACEN TABLETS | EACH FILM COATED TABLETS CONTAINES FLUPENTIXOL HYDROCHLORIDE BP EQUIVALENT TO FLUPENTIXOL 0.5 MG MELITRACEN HYDROCHLORIDE EQUIVALENT TO MELITRACEN 10 MG EXCIPIENTS Q.S. COLOUR: ERYTHROSINE | |
429 | TELMISARTAN 40 MG AND CHLORTHALIDONE 6.25 MG TABLETS | EACH UNCOATED BILAYERED TABLETS CONTAINES TELMISARTAN IP 40 MG CHLORTHALIDONE IP 6.25 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP | |
430 | LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS IP | EACH FILM COATED TABLET CONTAINS LEVOCETIRIZINE DIHYDROCHLORIDE IP 5 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE | IP |
431 | PHENYLEPHRINE HCL, CHLORPHENIRAMINE MALEATE AND SODIUM CITRATE SYRUP | EACH 5 ML CONTAINS PHENYLEPHRINE HCl IP 5 MG CHLORPHENIRAMINE MALEATE IP 2 MG SODIUM CITRATE IP 60 MG IN A FLAVOURED SYRUPY BASE Q.S. COLOUR: PONCEAU-4R | |
432 | DIVALPROEX SODIUM EXTENDED RELEASE TABLETS IP 750 MG | EACH FILM-COATED EXTENDED RELEASE TABLET CONTAINS DIVALPROEX SODIUM IP EQ. TO VALPROIC ACID 750 MG EXCIPIENTS Q.S. COLOUR: FERRIC OXIDE BLACK & TITANIUM DIOXIDE IP | IP |
433 | ROXITHROMYCIN TABLETS IP 150 MG | EACH FILM COATED TABLET CONTAINS ROXITHROMYCIN IP 150 MG EXCIPIENTS Q.S. COLOUR: LAKE OF BRILLIANT BLUE & TITANIUM DIOXIDE IP | IP |
434 | LETROZOLE TABLETS IP 2.5 MG | EACH FILM COATED TABLET CONTAINS LETROZOLE IP 2.5 MG EXCIPIENTS Q.S. COLOUR: YELLOW OXIDE OF IRON & TITANIUM DIOXIDE IP | IP |
435 | RUPATADINE TABLETS 10 MG | EACH UNCOATED TABLET CONTAINS RUPATADINE FUMARATE IP EQ. TO RUPATADINE 10 MG EXCIPIENTS Q.S. | |
436 | ATENOLOL TABLETS IP 50 MG | EACH UNCOATED TABLET CONTAINS ATENOLOL IP 50 MG EXCIPIENTS Q.S. | IP |
437 | ETORICOXIB TABLETS IP | EACH FILM COATED TABLET CONTAINS ETORICOXIB IP 90 MG EXCIPIENTS Q.S. COLOUR: PEA GREEN & TITANIUM DIOXIDE IP | IP |
438 | SODIUM PICOSULPHATE TABLETS 10 MG | EACH FILM COATED TABLET CONTAINS SODIUM PICOSULPHATE BP 10 MG EXCIPIENTS Q.S. COLOUR: TARTRAZINE | |
439 | MOXIFLOXACIN HYDROCHLORIDE TABLETS IP | EACH FILM COATED TABLET CONTAINS MOXIFLOXACIN HCl IP EQ. TO MOXIFLOXACIN 400 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON & TITANIUM DIOXIDE IP | IP |
440 | PARACETAMOL, PHENYLEPHRINE HCl, CAFFEINE AND DIPHENHYDRAMINE HCl TABLETS | EACH UNCOATED TABLET CONTAINS PARACETAMOL IP 500 MG PHENYLEPHRINE Hcl IP 5 MG CAFFEINE (ANHYDROUS) IP 30 MG DIPHENHYDRAMINE Hcl IP 25 MG EXCIPIENTS Q.S. | |
441 | ESOMEPRAZOLE GASTRO-RESISTANT AND DOMPERIDONE SUSTAINED-RELEASE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS ESOMEPRAZOLE MAGNESIUM TRIHYDRATE IP EQ. TO ESOMEPRAZOLE 20 MG (AS ENTERIC COATED PELLETS) DOMPERIDONE IP 10 MG (AS IMMEDIATE-RELEASE PELLETS) DOMPERIDONE IP 20 MG (AS SUSTAINED-RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY CAPSULES SHELL AND PELLETS | |
442 | METFORMIN HYDROCHLORIDE PROLONGED-RELEASE AND GLIMEPIRIDE TABLETS IP | EACH UNCOATED BILAYERED TABLET CONTAINS METFORMIN HCL IP 1000 MG (IN PROLONGED-RELEASE FROM) GLIMEPIRIDE IP 2 MG EXCIPIENTS Q.S. COLOUR: TARTRAZINE | IP |
443 | METFORMIN HYDROCHLORIDE PROLONGED-RELEASE AND GLIMEPIRIDE TABLETS IP | EACH UNCOATED BILAYERED TABLET CONTAINS METFORMIN HCL IP 1000 MG (IN PROLONGED-RELEASE FROM) GLIMEPIRIDE IP 1 MG EXCIPIENTS Q.S. COLOUR: SUNSET YELLOW | IP |
444 | TELMISARTAN TABLETS IP 40 MG | EACH UNCOATED TABLET CONTAINS TELMISARTAN IP 40 MG EXCIPIENTS Q.S. | IP |
445 | TELMISARTAN AND HYDROCHLORTHIAZIDE TABLETS IP | EACH UNCOATED BILAYERED TABLET CONTAINS TELMISARTAN IP 40 MG HYDROCHLORTHIAZIDE IP 12.5 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON | IP |
446 | VILDAGLIPTIN AND METFORMIN HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS VILDAGLIPTIN 50 MG METFORMIN HCL IP 500 MG EXCIPIENTS Q.S. COLOUR: YELLOW OXIDE OF IRON & TITANIUM DIOXIDE IP | |
447 | VILDAGLIPTIN TABLETS | EACH UNCOATED TABLET CONTAINS VILDAGLIPTIN 50 MG EXCIPIENTS Q.S. | |
448 | ESOMEPRAZOLE 40 MG (EC) & ITOPRIDE HYDROCHLORIDE 150 MG (SR) CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS ESOMEPRAZOLE MAGNESIUM TRIHYDRATE IP EQ. TO ESOMEPRAZOLE 40 MG (AS ENTERIC COATED PELLETS) ITOPRIDE HCl IP 150 MG (AS SUSTAINED RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL & PELLETS. | |
449 | PANTOPRAZOLE 40 MG (EC) & ITOPRIDE HYDROCHLORIDE 150 MG (SR) CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS PANTOPRAZOLE SODIUM SESQUIHYDRATE IP EQ. TO PANTOPRAZOLE 40 MG (AS ENTERIC COATED PELLETS) ITOPRIDE HCl IP 150 MG (AS SUSTAINED RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL & PELLETS. | |
450 | ESOMEPRAZOLE GASTRO-RESISTANT AND DOMPERIDONE SUSTAINED-RELEASE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS ESOMEPRAZOLE MAGNESIUM TRIHYDRATE IP EQ. TO ESOMEPRAZOLE 40 MG (AS ENTERIC COATED PELLETS) DOMPERIDONE IP 10 MG (AS IMMEDIATE-RELEASE PELLETS) DOMPERIDONE IP 20 MG (AS SUSTAINED-RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY CAPSULES SHELL AND PELLETS | |
451 | ITOPRIDE TABLETS IP | EACH FILM COATED TABLET CONTAINS ITOPRIDE HYDROCHLORIDE IP 50 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP | IP |
452 | ITOPRIDE TABLETS IP | EACH FILM COATED TABLET CONTAINS ITOPRIDE HYDROCHLORIDE IP 150 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP | IP |
453 | RANITIDINE ORAL SOLUTION IP | EACH 5 ML CONTAINS RANITIDINE HYDROCHLORIDE IP EQ. TO RANITIDINE 75 MG FLAVOURED SYRUP BASE COLOUR: QUINOLINE YELLOW WS | IP |
454 | CITICOLINE AND PIRACETAM TABLETS | EACH FILM COATED TABLET CONTAINS CITICOLINE SODIUM IP EQ. TO CITICOLINE 500 MG PIRACETAM IP 800 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP | |
455 | PREGABALIN SUSTAINED RELEASE & METHYLCOBALAMIN TABLETS | EACH UNCOATED TABLETS CONTAINS PREGABALIN IP 75 MG (IN SUSTAINED RELEASE FORM) METHYLCOBALAMIN IP 1500 MCG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON | |
456 | CHLORPHENIRAMINE MALEATE & PHENYLEPHRINE HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS CHLORPHENIRAMINE MALEATE IP 2 MG PHENYLEPHRINE HCl IP 5 MG IN A FLAVOURED SYRUP BASE COLOUR:PANCEAU 4R | |
457 | FERACRYLUM GEL 1 % W/W | COMPOSITION FERACRYLUM 1 % W/W WATER MISCIBLE BASE Q.S. | |
458 | TAMSULOSIN HYDROCHLORIDE MODIFIED RELEASE AND DEFLAZACORT CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS TAMSULOSIN HYDROCHLORIDE IP 0.4 MG (AS FILM COATED MODIFIED RELEASE TABLETS) COLOUR: TITANIUM DIOXIDE IP DEFLAZACORT 30 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY CAPSULES SHELL | |
459 | DICYCLOMINE HYDROCHLORIDE & PARACETAMOL CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS DICYCLOMINE HCl IP 20 MG PARACETAMOL IP 325 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY CAPSULES SHELL | |
460 | CETIRIZINE HYDROCHLORIDE TABLETS IP | EACH FILM COATED TABLET CONTAINS CETIRIZINE HYDROCHLORIDE IP 10 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE | IP |
461 | PARACETAMOL, PHENYLEPHRINE HCl, CAFFEINE AND DIPHENHYDRAMINE HCl TABLETS | EACH FILM COATED TABLET CONTAINS PARACETAMOL IP 500 MG PHENYLEPHRINE Hcl IP 5 MG CAFFEINE (ANHYDROUS) IP 30 MG DIPHENHYDRAMINE Hcl IP 25 MG EXCIPIENTS Q.S. COLOUR: TARTRAZINE | |
462 | TRIHEXYPHENIDYL HYDROCHLORIDE TABLETS IP 2 MG | EACH UNCOATED TABLET CONTAINS TRIHEXYPHENIDYL HYDROCHLORIDE IP 2 MG EXCIPIENTS Q.S. | IP |
463 | BENZHEXOL HYDROCHLORIDE TABLETS IP | EACH UNCOATED TABLET CONTAINS BENZHEXOL HYDROCHLORIDE IP 5 MG EXCIPIENTS Q.S. | IP |
464 | PARACETAMOL AND THIOCOLCHICOSIDE TABLETS | EACH FILM COATED TABLET CONTAINS PARACETAMOL IP 325 MG THIOCOLCHICOSIDE IP 4 MG EXCIPIENTS Q.S. COLOUR: TARTRAZINE | |
465 | ATORVASTATIN TABLETS IP 80 MG | EACH FILM COATED TABLET CONTAIN ATORVASTATIN CALCIUM IP EQ. TO ATORVASTATIN 80 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP | IP |
466 | DEXLANSOPRAZOLE MODIFIED RELEASE AND DOMPERIDONE SUSTAINED RELEASE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS DEXLANSOPRAZOLE IP 30 MG (AS MODIFIED RELEASE PELLETS) DOMPERIDONE IP 30 MG (AS SUSTAINED RELEASE PELLETS) APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL AND PELLETS. | |
467 | DEXLANSOPRAZOLE MODIFIED RELEASE AND DOMPERIDONE SUSTAINED RELEASE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS DEXLANSOPRAZOLE IP 60 MG (AS MODIFIED RELEASE PELLETS) DOMPERIDONE IP 30 MG (AS SUSTAINED RELEASE PELLETS) APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL AND PELLETS. | |
468 | DEXLANSOPRAZOLE MODIFIED RELEASE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS DEXLANSOPRAZOLE IP 60 MG (AS MODIFIED RELEASE PELLETS) APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL AND PELLETS. | |
469 | MONTELUKAST SODIUM AND DESLORATADINE TABLETS | EACH FILM COATED TABLET CONTAINS MONTELUKAST SODIUM IP EQ. TO MONTELUKAST 10 MG DESLORATADINE BP 5 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON | |
470 | DEXLANSOPRAZOLE MODIFIED RELEASE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS DEXLANSOPRAZOLE IP 30 MG (AS MODIFIED RELEASE PELLETS) APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL AND PELLETS. | |
471 | VILDAGLIPTIN AND METFORMIN HYDROCHLORIDE (SR) TABLETS | EACH UNCOATED BILAYERED TABLET CONTAINS VILDAGLIPTIN 50 MG METFORMIN HCL IP 500 MG (AS SUSTAINED RELEASE FORM) EXCIPIENTS Q.S. COLOUR: QUINOLINE YELLOW | |
472 | TELMISARTAN & CHLORTHALIDONE TABLETS | EACH UNCOATED BILAYER TABLET CONTAINS TELMISARTAN IP 40 MG CHLORTHALIDONE IP 6.25 MG EXCIPIENTS Q.S. COLOUR: FERRIC OXIDE RED & FERRIC OXIDE YELLOW | |
473 | METOPROLOL SUCCINATE EXTENDED RELEASE TABLETS IP | EACH FILM COATED EXTENDED RELEASE TABLET CONTAINS METOPROLOL SUCCINATE IP 23.75 MG EQ. TO METOPROLOL TARTRATE 25 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP | IP |
474 | METOPROLOL SUCCINATE EXTENDED RELEASE TABLETS IP | EACH FILM COATED EXTENDED RELEASE TABLET CONTAINS METOPROLOL SUCCINATE IP 47.5 MG EQ. TO METOPROLOL TARTRATE 50 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP | IP |
475 | L-ORNITHINE L-ASPARTATE TABLETS 500 MG | EACH FILM COATED TABLET CONTAINS L-ORNITHINE L-ASPARTATE 500 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON & TITANIUM DIOXIDE IP | |
476 | L-ORNITHINE- L-ASPARTATE SYRUP | EACH 5 ML CONTAINS L-ORNITHINE- L-ASPARTATE 250 MG IN FLAVOURE SYRUPY BASE Q.S. | |
477 | LIQUID PARAFFIN & MILK OF MAGNESIA ORAL EMULSION | EACH 15 ML CONTAINS: LIQUID PARAFFIN IP 3.75 ML MILK OF MAGNESIA IP 11.25 ML IN A FLAVOURED SYRUP BASE Q.S. COLOUR: CARMOSINE & PONCEAU 4R | |
478 | RUPATADINE TABLETS 10 MG | EACH UNCOATED TABLET CONTAINS RUPATADINE FUMARATE IP EQ. TO RUPATADINE 10 MG EXCIPIENTS Q.S. | |
479 | ATENOLOL TABLETS IP 50 MG | EACH UNCOATED TABLET CONTAINS ATENOLOL IP 50 MG EXCIPIENTS Q.S. | IP |
480 | ETORICOXIB TABLETS IP | EACH FILM COATED TABLET CONTAINS ETORICOXIB IP 90 MG EXCIPIENTS Q.S. COLOUR: PEA GREEN & TITANIUM DIOXIDE IP | IP |
481 | SODIUM PICOSULPHATE TABLETS 10 MG | EACH FILM COATED TABLET CONTAINS SODIUM PICOSULPHATE BP 10 MG EXCIPIENTS Q.S. COLOUR: TARTRAZINE | |
482 | MOXIFLOXACIN HYDROCHLORIDE TABLETS IP | EACH FILM COATED TABLET CONTAINS MOXIFLOXACIN HCL IP EQ. TO MOXIFLOXACIN 400 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON & TITANIUM DIOXIDE IP | 06IP |
483 | PARACETAMOL, PHENYLEPHRINE HCL, CAFFEINE AND DIPHENHYDRAMINE HCL TABLETS | EACH UNCOATED TABLET CONTAINS PARACETAMOL IP 500 MG PHENYLEPHRINE HCL IP 5 MG CAFFEINE (ANHYDROUS) IP 30 MG DIPHENHYDRAMINE HCL IP 25 MG EXCIPIENTS | |
484 | PREGABALIN 75 MG (PROLONGED RELEASE) AND ETORICOXIB TABLETS | EACH FILM COATED BILAYERED TABLET CONTAINS PREGABALIN IP 75 MG (AS PROLONGED RELEASE) ETORICOXIB IP 60 MG EXCIPIENTS Q.S. COLOUR: ERYTHROSINE | |
485 | TAMSULOSIN HYDROCHLORIDE (MODIFIED RELEASE) DUTASTERIDE TABLETS | EACH FILM COATED TABLET CONTAINS TAMSULOSIN HYDROCHLORIDE IP 0.4 MG (AS MODIFIED RELEASE) DUTASTERIDE IP 0.5 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP | |
486 | DEXTROMETHORPHAN HYDROBROMIDE, CHLORPHENIRAMINE MALEATE AND PHENYLEPHRINE HYDROCHLORIDE FLAVOURED DISPERSIBLE TABLETS | EACH UNCOATED FLAVOURED DISPERSIBLE TABLET CONTAINS DEXTROMETHORPHAN HBR IP 10 MG CHLORPHENIRAMINE MALEATE IP 2 MG PHENYLEPHRINE HCL IP 5 MG EXCIPIENTS Q.S. | |
487 | BILASTINE & MONTELUKAST TABLETS | EACH FILM COATED TABLET CONTAINS BILASTINE 20 MG MONTELUKAST SODIUM IP EQ. TO MONTELUKAST 10 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON | |
488 | OMEPRAZOLE MAGNESIUM TABLETS | EACH ENTERIC COATED TABLET CONTAINS OMEPRAZOLE MAGNESIUM IP EQ. TO OMEPRAZOLE 40 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON | |
489 | METHYLPREDNISOLONE TABLETS IP | EACH UNCOATED TABLET CONTAINS: METHYLPREDNISOLONE IP 16 MG EXCIPIENTS Q.S. | IP |
490 | METHYLPREDNISOLONE TABLETS IP | EACH UNCOATED TABLET CONTAINS: METHYLPREDNISOLONE IP 8 MG EXCIPIENTS Q.S. | IP |
491 | CARISOPRODOL TABLETS IP 350 MG | EACH UNCOATED TABLET CONTAINS: CARISOPRODOL IP 350 MG EXCIPIENTS Q.S. | IP |
492 | MIRTAZAPINE TABLETS IP 15 MG | EACH FILM COATED TABLET CONTAINS: MIRTAZAPINE IP 15 MG EXCIPIENTS Q.S. COLOUR: TARTRAZINE | IP |
493 | RIFAXIMIN TABLETS | EACH FILM COATED TABLET CONTAINS: RIFAXIMIN BP 550 MG EXCIPIENTS Q.S. COLOUR: SUNSET YELLOW FCF & TITANIUM DIOXIDE IP | |
494 | DEFLAZACORT SUSPENSION | EACH 5 ML CONTAINS: DEFLAZACORT 6 MG IN A FLAVOURED SYRUPY BASE Q.S. COLOUR: QUINOLINE YELLOW | |
495 | CHLORHEXIDINE GLUCONATE 0.2% AND MENTHOL 0.1% MOUTH WASH | COMPOSITION CHLORHEXIDINE GLUCONATE SOLUTION IP EQ. TO CHLORHEXIDINE GLUCONATE 0.20 % W/W MENTHOL 0.10 % W/W AQUEOUS BASE Q.S. COLOUR: BRILLIANT BLUE | |
496 | GLICLAZIDE (MR) AND METFORMIN HYDROCHLORIDE (SR) TABLETS | EACH UNCOATED BILAYERED TABLETS CONTAINS: GLICLAZIDE IP 30 MG (AS MODIFIED RELEASED) METFORMIN HYDROCHLORIDE IP 500 MG (AS SUSTAINED RELEASE FORM) COLOUR: QUINILINE YELLOW | |
497 | GLICLAZIDE (MR) AND METFORMIN HYDROCHLORIDE (SR) TABLETS | EACH UNCOATED BILAYERED TABLETS CONTAINS: GLICLAZIDE IP 60 MG (AS MODIFIED RELEASED) METFORMIN HYDROCHLORIDE IP 500 MG (AS SUSTAINED RELEASE FORM) COLOUR: ERYTHROSINE | |
498 | GLICLAZIDE (SR), METFORMIN HYDROCHLORIDE (SR) & PIOGLITAZON TABLETS | EACH UNCOATED BILAYERED TABLETS CONTAINS: GLICLAZIDE IP 60 MG (AS SUSTAINED RELEASE FORM) METFORMIN HYDROCHLORIDE IP 500 MG (AS SUSTAINED RELEASE FORM) PIOGLITAZONE HYDROCHLORIDE IP EQ. TO PIOGLITAZON 15 MG COLOUR: QUINILINE YELLOW | |
499 | GLICLAZIDE (SR), METFORMIN HYDROCHLORIDE (SR) & PIOGLITAZON TABLETS | EACH UNCOATED BILAYERED TABLETS CONTAINS: GLICLAZIDE IP 60 MG (AS SUSTAINED RELEASE FORM) METFORMIN HYDROCHLORIDE IP 500 MG (AS SUSTAINED RELEASE FORM) PIOGLITAZONE HYDROCHLORIDE IP EQ. TO PIOGLITAZON 15 MG COLOUR: SUNSET YELLOW | |
500 | DICLOFENAC TABLETS IP | EACH UNCOATED TABLET CONTAINS DICLOFENAC SODIUM IP 50 MG EXCIEPINTS Q.S. | IP |
501 | PARACETAMOL, PHENYLEPHRINE HCL & CHLORPHENIRAMINE MALEATE SUSPENSION | EACH 5 ML CONTAINS PARACETAMOL IP 125 MG PHENYLEPHRINE HCL IP 5 MG CHLORPHENIRAMINE MALEATE IP 1 MG FLAVOURED SYRUPY BASE Q.S. COLOUR: SUNSET YELLOW FCF | |
502 | CALCIUM CARBONATE, VITAMIN D3, METHYLCOBALAMIN, L-METHYLFOLATE CALCIUM & PYRIDOXAL-5-PHOSPHATE TABLETS | EACH FILM COATED TABLET CONTAINS CALCIUM CARBONATE IP 1250 MG VITAMIN D3 IP 2000 IU METHYLCOBALAMIN IP 1500 MCG CALCIUM L-5-METHYLTETRAHYDROFOLATE USP 1 MG (L-METHYLFOLATE CALCIUM) PYRIDOXAL-5-PHOSPHATE 20 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP | |
503 | FRUSEMIDE TABLETS IP 40 MG | EACH UNCOATED TABLETS CONTAINS FRUSEMIDE IP 40 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE | IP |
504 | PARACETAMOL, PHENYLEPHRINE HCL, CAFFEINE AND DIPHENHYDRAMINE HCL TABLETS | EACH UNCOATED TABLET CONTAINS PARACETAMOL IP 500 MG PHENYLEPHRINE HCL IP 10 MG CAFFEINE (ANHYDROUS) IP 25 MG DIPHENHYDRAMINE HCL IP 25 MG EXCIPIENTS | |
505 | LOXAPINE CAPSULES USP | EACH HARD GELATIN CAPSULE CONTAINS: LOXAPINE SUCCINATE USP EQ. TO LOXAPINE 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULES SHELL AND PELLETS | USP |
506 | GLIPIZIDE TABLETS IP 5 MG | EACH UNCOATED TABLET CONTAINS GLIPIZIDE IP 5 MG EXCIPIENTS Q.S. | IP |
507 | CINNARIZINE TABLETS IP | EACH FILM COATED TABLET CONTAINS CINNARIZINE IP 25 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE | IP |
508 | CHLORAMPHENICOL CAPSULES IP | EACH HARD GELATIN CAPSULE CONTAINS CHLORAMPHENICOL IP 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY CAPSULES SHELLS | IP |
509 | ESCITALOPRAM OXALATE TABLETS IP | EACH FILM COATED TABLET CONTAINS ESCITALOPRAM OXALATE IP EQ. TO ESCITALOPRAM 20 MG EXCIPIENTS Q.S. COLOUR: YELLOW OXIDE OF IRON | IP |
510 | METOPROLOL SUCCINATE & RAMIPRIL TABLETS | EACH FILM COATED TABLET CONTAINS METOPROLOL SUCCINATE IP 23.75 MG EQ. TO METOPROLOL TARTRATE 25 MG RAMIPRIL IP 2.5 MG EXCIPIENTS Q.S. COLOUR: SUNSET YELLOW | |
511 | CARVEDILOL EXTENDED RELEASE TABLETS 10 MG | EACH UNCOATED EXTENDED RELEASE TABLET CONTAINS CARVEDILOL IP 10 MG EXCIPIENTS Q.S | |
512 | CARVEDILOL EXTENDED RELEASE TABLETS 20 MG | EACH UNCOATED EXTENDED RELEASE TABLET CONTAINS CARVEDILOL IP 20 MG EXCIPIENTS Q.S. | |
513 | ITOPRIDE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS ITOPRIDE HYDROCHLORIDE IP 50 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE | IP |
514 | CARVEDILOL EXTENDED RELEASE TABLETS 25 MG | EACH UNCOATED EXTENDED RELEASE TABLET CONTAINS CARVEDILOL IP 25 MG EXCIPIENTS Q.S. | |
515 | NORTRIPTYLINE TABLETS IP | EACH FILM COATED TABLET CONTAINS NORTRIPTYLINE HYDROCHLORIDE IP EQ.TO NORTRIPTYLINE 25 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE | IP |
516 | PIROXICAM DISPERSIBLE TABLETS 20 MG | EACH UNCOATED DISPERSIBLE TABLET CONTAINS PIROXICAM IP 20 MG (IN A FLAVORED BASE) EXCIPIENTS Q.S. | |
517 | RANITIDINE TABLETS IP 150 MG | EACH FILM COATED TABLET CONTAINS RANITIDINE HYDROCHLORIDE IP EQ. TO RANITIDINE 150 MG EXCIPIENTS Q.S. COLOUR: SUNSET YELLOW | IP |
518 | PREDNISOLONE TABLETS IP 10 MG | EACH UNCOATED TABLET CONTAINS PREDNISOLONE IP 10 MG EXCIPIENTS Q.S. | IP |
519 | CINNARIZINE & DOMPERIDONE TABLETS | EACH FILM COATED TABLET CONTAINS CINNARIZINE IP 20 MG DOMPERIDONE IP 15 MG EXCIPIENTS Q.S. COLOUR: TARTRAZINE YELLOW | |
520 | DIACEREIN CAPSULES IP 50 MG | EACH HARD GELATIN CAPSULE CONTAINS DIACEREIN IP 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY CAPSULES SHELLS | IP |
521 | GLIBENCLAMIDE TABLETS IP 5 MG | EACH UNCOATED TABLET CONTAINS GLIBENCLAMIDE IP 5 MG EXCIPIENTS Q.S. | IP |
522 | HALOPERIDOL TABLETS IP 5 MG | EACH UNCOATED TABLET CONTAINS HALOPERIDOL IP 5 MG EXCIPIENTS Q.S. | IP |
523 | AMBROXOL HYDROCHLORIDE & LEVOCETIRIZINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS AMBROXOL HYDROCHLORIDE IP 60 MG LEVOCETIRIZINE HYDROCHLORIDE IP 5 MG EXCIPIENTS Q.S. COLOUR: QUINOLINE YELLOW | |
524 | SALBUTAMOL TABLETS IP 2 MG | EACH UNCOATED TABLET CONTAINS SALBUTAMOL SULPHATE IP EQ. TO SALBUTAMOL 2 MG EXCIPIENTS Q.S. | IP |
525 | SALBUTAMOL TABLETS IP 4 MG | EACH UNCOATED TABLET CONTAINS SALBUTAMOL SULPHATE IP EQ. TO SALBUTAMOL 4 MG EXCIPIENTS Q.S. | IP |
526 | RANITIDINE & DOMPERIDONE TABLETS | EACH FILM COATED TABLET CONTAINS RANITIDINE HYDROCHLORIDE IP EQ. TO RANITIDINE 150 MG DOMPERIDONE IP 10 MG EXCIPIENTS Q.S. COLOUR: SUSET YELLOW | |
527 | BROMHEXINE HYDROCHLORIDE, GUAIPHENESIN PARACETAMOL, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE & TABLETS | EACH UNCOATED TABLET CONTAINS PARACETAMOL IP 325 MG BROMHEXINE HYDROCHLORIDE IP 8 MG CHLORPHENIRAMINE MALEATE IP 2 MG PHENYLEPHRINE HYDROCHLORIDE IP 10 MG GUAIPHENESIN IP 100 MG EXCIPIENTS Q.S. | |
528 | DISULFIRAM TABLETS IP 500 MG | EACH UNCOATED TABLET CONTAINS DISULFIRAM IP 500 MG EXCIPIENTS Q.S. | IP |
529 | AZELNIDIPINE TABLETS IP 8 MG | EACH UNCOATED TABLET CONTAINS AZELNIDIPINE IP 8 MG EXCIPIENTS Q.S. | IP |
530 | FURAZOLIDONE & METRONIDAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS FURAZOLIDONE IP 100 MG METRONIDAZOLE IP 200 MG EXCIPIENTS Q.S. | |
531 | INDOMETHACIN CAPSULE IP 25 MG | EACH HARD GELATIN CAPSULE CONTAINS : INDOMETHACIN IP 25 MG APPROVED COLOUR USED | IP |
532 | SILDENAFIL CITRATE AND DAPOXETINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS : SILDENAFIL CITRATE IP EQ. TO SILDENAFIL 50 MG DAPOXETINE HYDROCHLORIDE IP EQ. TO DAPOXETINE 30 MG EXCIPIENTS Q.S. | |
533 | PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, SODIUM CITRATE, DEXTROMETHORPHAN HYDROBROMIDE & MENTHOL SUSPENSION | EACH 5 ML CONTAINS PARACETAMOL IP 250 MG PHENYLEPHRINE HYDROCHLORIDE IP 5 MG CETIRIZINE HYDROCHLORIDE IP 2.5 MG SODIUM CITRATE IP 25 MG DEXTROMETHORPHAN HYDROBROMIDE IP 5 MG MENTHOL IP 1 MG FLAVOURED PALATABLE BASE Q.S. COLOUR: SUNSET YELLOW FCF | |
534 | NIMESULIDE FLAVOURED DISPERSIBLE TABLETS 100 MG | EACH UNCOATED DISPERSIBLE TABLETS CONTAINS NIMESULIDE BP 100 MG EXCIPIENTS Q.S. NOT FOR USE BELOW 12 YEARS OF AGE | |
535 | DAPOXETINE HYDROCHLORIDE IP 60 MG AND SILDENAFIL CITRATE IP 100 MG TABLETS | EACH FILM COATED TABLET CONTAINS DAPOXETINE HYDROCHLORIDE IP EQ. TO DAPOXETINE 60 MG SILDENAFIL CITRATE IP EQ. TO SILDENAFIL 100 MG EXCIPIENTS Q.S. COLOUR: BRILLIANT BLUE & TARTRAZINE | |
536 | SPIRONOLACTONE TABLETS IP | EACH UNCOATED TABLET CONTAINS SPIRONOLACTONE IP 25 MG EXCIPIENTS Q.S. | IP |
537 | TORSEMIDE TABLETS IP 10 MG | EACH UNCOATED TABLET CONTAINS TORSEMIDE IP 10 MG EXCIPIENTS Q.S. | IP |
538 | NIFEDIPINE SR TABLETS IP 20 MG | EACH FILM COATED SUSTAINED RELEASE TABLET CONTAINS NIFEDIPINE IP 20 MG EXCIPIENTS Q.S. COLOUR: SUNSET YELLOW | IP |
539 | TORSEMIDE & SPIRONOLACTONE TABLETS | EACH UNCOATED TABLET CONTAINS TORSEMIDE IP 10 MG SPIRONOLACTONE IP 25 MG EXCIPIENTS Q.S. | |
540 | CHLORTHALIDONE TABLETS IP | EACH FILM COATED SUSTAINED RELEASE TABLET CONTAINS CHLORTHALIDONE IP 12.5 MG EXCIPIENTS Q.S. COLOUR: SUNSET YELLOW | IP |
541 | CHLORTHALIDONE, TELMISARTAN & AMLODIPINE TABLETS | EACH FILM COATED TABLET CONTAINS CHLORTHALIDONE IP 6.25 MG TELMISARTAN IP 40 MG AMLODIPINE BESYLATE IP EQ. TO AMLODIPINE 5 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP | |
542 | AMLODIPINE AND CHLORTHALIDONE TABLETS | EACH FILM TABLET CONTAINS AMLODIPINE BESYLATE IP EQ. TO AMLODIPINE 5 MG CHLORTHALIDONE IP 12.5 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP | |
543 | NAPROXEN SODIUM & DOMPERIDONE TABLETS | EACH FILM COATED BILAYER TABLET CONTAINS NAPROXEN SODIUM BP 500 MG DOMPERIDONE MALEATE IP EQ. TO DOMPERIDONE 10 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON | |
544 | AMISULPRIDE TABLETS | EACH UNCOATED TABLET CONTAINS AMISULPRIDE IP 200 MG EXCIPIENTS Q.S. | |
545 | ETODOLAC EXTENDED RELEASE TABLETS IP | EACH FILM COATED EXTENDED RELEASE TABLET CONTAINS ETODOLAC 600 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE | IP |
546 | TOLPERISONE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS TOLPERISONE HYDROCHLORIDE 150 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE | |
547 | DAPOXETINE HYDROCHLORIDE IP TABLETS 30 MG | EACH FILM COATED TABLET CONTAINS DAPOXETINE HYDROCHLORIDE IP EQ. TO DAPOXETINE 30 MG EXCIPIENTS Q.S. COLOUR: BRILLIANT BLUE & TARTRAZINE | IP |
548 | DAPOXETINE HYDROCHLORIDE IP TABLETS 60 | EACH FILM COATED TABLET CONTAINS DAPOXETINE HYDROCHLORIDE IP EQ. TO DAPOXETINE 60 MG EXCIPIENTS Q.S. COLOUR: BRILLIANT BLUE & TARTRAZINE | IP |
549 | PARACETAMOL, PHENYLEPHRINE HCL, CAFFEINE AND DIPHENHYDRAMINE HCL TABLETS | EACH UNCOATED TABLET CONTAINS PARACETAMOL IP 500 MG PHENYLEPHRINE HCL IP 10 MG CAFFEINE (ANHYDROUS) IP 30 MG DIPHENHYDRAMINE HCL IP 25 MG EXCIPIENTS Q.S. | |
550 | SUCRALFATE & OXETACAINE SUSPENSION | EACH 5 ML CONTAINS SUCRALFATE IP 500 MG OXETACAINE BP 10 MG FLAVOURED SYRUPY BASE Q.S | |
551 | SILVER SULFADIAZINE & CHLORHEXIDINE GLUCONATE CREAM | COMPOSITION SILVER SULFADIAZINE IP 1.00 % W/W CHLORHEXIDINE GLUCONATE SOLUTION IP 0.20 % W/W CHLOROCRESOL IP 0.10 % W/W (AS PRESERVATIVE) CREAM BASE Q.S. | |
552 | PARACETAMOL, PHENYLEPHRINE HCL, CAFFEINE AND DIPHENHYDRAMINE HCL TABLETS | EACH UNCOATED TABLET CONTAINS PARACETAMOL IP 500 MG PHENYLEPHRINE HCL IP 10 MG CAFFEINE (ANHYDROUS) IP 30 MG DIPHENHYDRAMINE HCL IP 25 MG EXCIPIENTS Q.S. | |
553 | BACLOFEN EXTENDED RELEASE CAPSULES | EACH EXTENDED RELEASE (GRS) CAPSULE CONTAINS BACLOFEN IP 30 MG APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL. | |
554 | BETAHISTINE HCl TABLETS IP 16 MG | EACH UNCOATED TABLET CONTAINS BETAHISTINE HYDROCHLORIDE IP 16 MG EXCIPIENTS Q.S. | IP |
555 | RABEPRAZOLE (EC) & ITOPRIDE HYDROCHLORIDE (SR) CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS RABEPRAZOLE SODIUM IP 20 MG (AS ENTERIC COATED PELLETS) ITOPRIDE HYDROCHLORIDE IP 150 MG (AS SUSTAINED RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL & PELLETS. | |
556 | ESOMEPRAZOLE ENTERIC COATED AND LEVOSULPIRIDE SUSTAINED-RELEASE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS ESOMEPRAZOLE MAGNESIUM TRIHYDRATE IP EQ. TO ESOMEPRAZOLE 40 MG (AS ENTERIC COATED PELLETS) LEVOSULPIRIDE IP 75 MG (AS SUSTAINED-RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY CAPSULES SHELL AND PELLETS | |
557 | ERGOTAMINE TARTRATE, CAFFEINE, PARACETAMOL & PROCHLORPERAZINE MALEATE TABLETS | EACH FILM COATED TABLET CONTAINS ERGOTAMINE TARTRATE IP 1 MG CAFFEINE (MONOHYDRATE) IP 100 MG PARACETAMOL IP 250 MG PROCHLORPERAZINE MALEATE IP 2.5 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON | |
558 | DEXTROMETHORPHAN HYDROBROMIDE, CHLORPHENIRAMINE MALEATE & MENTHOL SYRUP | EACH 5 ML CONTAINS DEXTROMETHORPHAN HYDROBROMIDE IP 10 MG CHLORPHENIRAMINE MALEATE IP 4 MG MENTHOL IP 2 MG FLAVOURED SYRUPY BASE Q.S. COLOUR: SUNSET YELLOW | |
559 | BISOPROLOL FUMARATE & AMLODIPINE BESYLATE TABLETS | EACH UNCOATED TABLET CONTAIN BISOPROLOL FUMARATE IP 2.5MG AMLODIPINE BESYLATE IP EQ. TO AMLODIPINE 5 MG EXCIPIENTS Q.S. | |
560 | BISOPROLOL FUMARATE & AMLODIPINE BESYLATE TABLETS | EACH UNCOATED TABLET CONTAIN BISOPROLOL FUMARATE IP 5MG AMLODIPINE BESYLATE IP EQ. TO AMLODIPINE 5 MG EXCIPIENTS Q.S COLOUR: TITANIUM DIOXIDE IP | |
561 | AMLODIPINE AND HYDROCHLOROTHIAZI-DE TABLETS | EACH UNCOATED TABLET CONTAIN AMLODIPINE BESYLATE IP EQ. TO AMLODIPINE 5 MG HYDROCHLOROTHIAZIDE IP 12.5 MG EXCIPIENTS Q.S. | |
562 | CILNIDIPINE TABLETS IP | EACH FILM COATED TABLET CONTAINS: CILNIDIPINE IP 5 MG EXCIPIENTS Q.S COLOUR : IRON OXIDE YELLOW & TITANIUM DIOXIDE | IP |
563 | CILNIDIPINE TABLETS IP | EACH FILM COATED TABLET CONTAINS: CILNIDIPINE IP 10 MG EXCIPIENTS Q.S COLOUR : IRON OXIDE YELLOW & TITANIUM DIOXIDE | IP |
564 | CILNIDIPINE TABLETS IP | EACH FILM COATED TABLET CONTAINS: CILNIDIPINE IP 20 MG EXCIPIENTS Q.S. COLOUR : TITANIUM DIOXIDE | IP |
565 | ATORVASTATIN TABLETS IP 40 MG | EACH FILM COATED TABLET CONTAINS: ATORVASTATIN CALCIUM IP EQ. TO ATORVASTATIN 40 MG EXCIPIENTS Q.S COLOUR : TITANIUM DIOXIDE IP | IP |
566 | ATORVASTATIN AND ASPIRIN CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: ATORVASTATIN CALCIUM IP EQ. TO ATORVASTATIN 10 MG ASPIRIN IP 75 MG (AS GASTRO RESISTANT TABLLET) APPROVED COLOUR USED IN EMPTY CAPSULES SHELLS | |
567 | ATORVASTATIN 10 MG AND FENOFIBRATE 160 MG IP TABLETS | EACH FILM COATED TABLET CONTAINS: ATORVASTATIN CALCIUM IP EQ. TO ATORVASTATIN 10 MG FENOFIBRATE IP 160 MG COLOUR: LAKE INDIGO CARMINE & TITANIUM DIOXIDE IP | IP |
568 | ATORVASTATIN AND CLOPIOGREL TABLETS | EACH UNCOATED BILAYER TABLET CONTAINS : ATORVASTATIN CALCIUM IP EQ. TO ATORVASTATIN 10MG CLOPIOGREL BISULPHATE IP EQ. TO CLOPIOGREL 75MG EXCIPIENT Q.S. COLOUR : RED OXIDE OF IRON | |
569 | LOSARTAN & HYDROCHLORO-THIAZIDE TABLETS IP | EACH FILM COATED TABLET CONTAINS: LOSARTAN POTASSIUM IP 50 MG HYDROCHLOROTHIAZIDE IP 12.5 MG EXCIPIENTS Q.S. COLOUR:TITANIUM DIOXIDE IP | IP |
570 | ROSUVASTATIN TABLETS IP 40 MG | EACH FILM COATED TABLET CONTAINS: ROSUVASTATIN CALCIUM IP EQ. TO ROSVASTATIN 40 MG EXCIPIENTS Q.S. COLOURS : RED OXIDE OF IRON & TITANIUM DIOXIDE IP | IP |
571 | ROSUVASTATIN AND FENOFIBRATE TABLETS IP | EACH FILM COATED TABLET CONTAINS: ROSUVASTATIN CALCIUM IP EQ. TO ROSVASTATIN 10 MG FENOFIBRATE IP 160 MG EXCIPIENTS Q.S. COLOURS : RED OXIDE OF IRON & TITANIUM DIOXIDE IP | IP |
572 | ROSUVASTATIN AND FENOFIBRATE TABLETS IP | EACH FILM COATED TABLET CONTAINS: ROSUVASTATIN CALCIUM IP EQ. TO ROSVASTATIN 20 MG FENOFIBRATE IP 160 MG EXCIPIENTS Q.S. COLOURS : TITANIUM DIOXIDE IP | IP |
573 | METOPROLOL SUCCINATE EXTENDED RELEASE TABLET IP 12.5 MG | EACH FILM COATED EXTENDED RELEASE TABLET CONTAIN : METOPROLOL SUCCINATE IP 11.875 MG EQ. TO METOPROLOL TARTRATE 12.5 MG EXCIPIENT Q.S. COLOUR : RED OXIDE OF IRON & TITANIUM DIOXIDE | IP |
574 | METOPROLOL PROLONGED RELEASE TABLETS IP | EACH FILM COATED PROLONGED RELEASE TABLET CONTAIN : METOPROLOL SUCCINATE IP 23.75 MG EQ. TO METOPROLOL TARTRATE 25 MG EXCIPIENT Q.S. COLOUR : TITANIUM DIOXIDE IP | IP |
575 | METOPROLOL PROLONGED RELEASE TABLETS IP | EACH FILM COATED PROLONGED RELEASE TABLET CONTAIN METOPROLOL SUCCINATE IP 47.5 MG EQ. TO METOPROLOL TARTRATE 50 MG EXCIPIENT Q.S. COLOUR : TITANIUM DIOXIDE IP | IP |
576 | TENELIGLIPTIN TABLETS 20 MG | EACH FILM COATED TABLET CONTAINS: TENELIGLIPTIN HYDROBROMIDE HYDRATE IP EQ. TO TENELIGLIPTIN 20 MG EXCIPIENTS Q.S. COLOUR : RED OXIDE OF IRON & TITANIUM DIOXIDE IP | |
577 | METFORMIN HYDROCHLORIDE SUSTAINED RLEASE TABLET IP | EACH UNCOATED SUSTAINED RELEASE TABLET CONTAIN : METFORMIN HYDROCHLORIDE IP 1000 MG EXCIPIENTS | IP |
578 | VOGLIBOSE, GLIMEPIRIDE AND METFORMIN HYDROCHLORIDE (SUSTAINED RELEASE) TABLETS | EACH UNCOATED BILAYERED TABLET CONTAINS: VOGLIBOSE IP 0.3 MG GLIMEPIRIDE IP 2 MG METFORMIN HYDROCHLORIDE IP 500 MG (IN SUSTAINED RELEASE FORM) EXCIPIENTS Q.S. COLOUR: FERRIC OXIDE USPNF YELLOW & FERRIC OXIDE USP NF RED | |
579 | VOGLIBOSE, GLIMEPIRIDE AND METFORMIN HYDROCHLORIDE (SUSTAINED RELEASE) TABLETS | EACH UNCOATED BILAYERED TABLET CONTAINS: VOGLIBOSE IP 0.2 MG GLIMEPIRIDE IP 2 MG METFORMIN HYDROCHLORIDE IP 500 MG (IN SUSTAINED RELEASE FORM) EXCIPIENTS Q.S. COLOUR: FERRIC OXIDE USPNF YELLOW & FERRIC OXIDE USP NF RED | |
580 | VOGLIBOSE TABLET IP 0.2 MG | EACH UNCOATED TABLET CONTAINS: VOGLIBOSE IP 0.2 MG EXCIPIENTS Q.S. | IP |
581 | VOGLIBOSE TABLET IP 0.3 MG | EACH UNCOATED TABLET CONTAINS: VOGLIBOSE IP 0.3 MG EXCIPIENTS Q.S. | IP |
582 | RAMIPRIL TABLETS IP | EACH UNCOATED TABLET CONTAINS: RAMIPRIL IP 2.5 MG EXCIPIENTS Q.S. COLOUR: YELLOW IRON OXIDE | IP |
583 | RAMIPRIL TABLETS IP | EACH UNCOATED TABLET CONTAINS: RAMIPRIL IP 5 MG EXCIPIENTS Q.S | IP |
584 | VILDAGLIPTIN AND METFORMIN HYDROCHLORIDE TABLET | EACH FILM COATED TABLET CONTAINS VILDAGLIPTIN IP 50 MG METFORMIN HYDROCHLORIDE IP 500 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP & YELLOW OXIDE OF IRON | |
585 | SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDE TABLET | EACH FILM COATED TABLET CONTAINS SITAGLIPTIN PHOSPHATE MONOHYDRATE IP 64.25MG EQ. TO SITAGLIPTIN 50 MG METFORMIN HYDROCHLORIDE IP 1000 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP & RED OXIDE OF IRON | |
586 | SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDE TABLET | EACH FILM COATED TABLET CONTAINS SITAGLIPTIN PHOSPHATE MONOHYDRATE IP 64.25 MG EQ. TO SITAGLIPTIN 50 MG METFORMIN HYDROCHLORIDE IP 500 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP & RED OXIDE OF IRON | |
587 | BISOPROLOL FUMARATE TABLET USP | EACH FILM COATED TABLET CONTAINS BISOPROLOL FUMARATE IP 2.5 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON & TITANIUM DIOXIDE IP | USP |
588 | BISOPROLOL FUMARATE TABLET USP | EACH FILM COATED TABLET CONTAINS BISOPROLOL FUMARATE IP 5 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON & TITANIUM DIOXIDE IP | USP |
589 | BISOPROLOL FUMARATE TABLET USP | EACH FILM COATED TABLET CONTAINS BISOPROLOL FUMARATE IP 10 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON & TITANIUM DIOXIDE IP | USP |
590 | DOXOFYLLINE AND AMBROXOL HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS DOXOFYLLINE IP 400 MG AMBROXOL HYDROCHLORIDE IP 30 MG EXCIPIENTS Q.S. | |
591 | DICLOFENAC SODIUM & PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: DICLOFENAC SODIUM IP 50 MG PARACETAMOL IP 250 MG EXCIPIENTS Q.S. | |
592 | PARACETAMOL AND CAFFEINE TABLET IP | EACH UNCOATED TABLET CONTAINS: PARACETAMOL IP 500 MG CAFFEINE IP EQ. ANHYDROUS CAFFEINE 50 MG EXCIPIENTS Q.S. | |
593 | TELMISARTAN TABLET IP 80 MG | EACH UNCOATED TABLET CONTAINS: TELMISARTAN IP 80 MG EXCIPIENTS Q.S. | IP |
594 | GLIMEPIRIDE TABLET IP 3 MG | EACH UNCOATED TABLET CONTAINS: GLIMEPIRIDE IP 3 MG EXCIPIENT Q.S. COLOUR: YELLOW OXIDE OF IRON | IP |
595 | GLIMEPIRIDE TABLET IP 4 MG | EACH FILM COATED TABLET CONTAINS: GLIMEPIRIDE IP 4MG EXCIPIENT Q.S. COLOUR: QUINOLINE YELLOW | IP |
596 | RABEPRAZOLE SODIUM TABLET 40 MG | EACH ENTERIC COATED TABLET CONTAINS: RABEPRAZOLE SODIUM IP 40 MG COLOUR : YELLOW OXIDE OF IRON & TITANIUM DIOXIDE IP | |
597 | GLIMEPIRIDE & METFORMIN HYDROCHLORIDE (SR) TABLETS IP | EACH UNCOATED BILAYERED TABLETS CONTAINS: GLIMEPIRIDE IP 3 MG METFORMIN HYDROCHLORIDE IP 500 MG (IN A SUSTAINED RELEASE FORM) EXCIPIENTS Q.S COLOUR : RED OXIDE OF IRON | IP |
598 | GLIMEPIRIDE & METFORMIN HYDROCHLORIDE (SR) TABLETS IP | EACH UNCOATED BILAYERED TABLETS CONTAINS GLIMEPIRIDE IP 4 MG METFORMIN HYDROCHLORIDE IP 500 MG (IN A SUSTAINED RELEASE FORM) EXCIPIENTS Q.S COLOUR : RED OXIDE OF IRON | IP |
599 | GLIMEPIRIDE & METFORMIN HYDROCHLORIDE (SR) TABLETS IP | EACH FILM COATED TABLETS CONTAINS GLIMEPIRIDE IP 2 MG METFORMIN HYDROCHLORIDE IP 850 MG (IN A SUSTAINED RELEASE FORM) EXCIPIENTS Q.S COLOUR : RED OXIDE OF IRON & TITANIUM DIOXIDE IP | IP |
600 | GLIMEPIRIDE & METFORMIN HYDROCHLORIDE (SR) TABLETS IP | EACH FILM COATED TABLETS CONTAINS GLIMEPIRIDE IP 3 MG METFORMIN HYDROCHLORIDE IP 850 MG (IN A SUSTAINED RELEASE FORM) EXCIPIENTS Q.S COLOUR : RED OXIDE OF IRON & TITANIUM DIOXIDE IP | IP |
601 | GLIMEPIRIDE & METFORMIN HYDROCHLORIDE (SR) TABLETS IP | EACH FILM COATED TABLETS CONTAINS GLIMEPIRIDE IP 4 MG METFORMIN HYDROCHLORIDE IP 850 MG (IN A SUSTAINED RELEASE FORM) EXCIPIENTS Q.S COLOUR : RED OXIDE OF IRON & TITANIUM DIOXIDE IP | IP |
602 | PIOGLITAZONE HYDROCHLORIDE TABLET IP | EACH UNCOATED TABLET CONTAINS PIOGLITAZONE HYDROCHLORIDE IP EQ. TO PIOGLITAZONE 15 MG EXCIPIENTS Q.S. | IP |
603 | PIOGLITAZONE HYDROCHLORIDE TABLET IP | EACH UNCOATED TABLET CONTAINS PIOGLITAZONE HYDROCHLORIDE IP EQ. TO PIOGLITAZONE 30 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON | IP |
604 | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE (SR) TABLET | EACH UNCOATED TABLET CONTAINS PIOGLITAZONE HYDROCHLORIDE IP EQ. TO PIOGLITAZONE 15 MG METFORMIN HYDROCHLORIDE IP 500 MG (IN A SUSTAINED RELEASE FORM) EXCIPIENTS Q.S. COLOUR: YELLOW OXIDE OF IRON | |
605 | DICLOFENAC SODIUM SUSTAINED RELEASE TABLET IP | EACH SUSTAINED RELEASE FILM COATED TABLET CONTAINS DICLOFENAC SODIUM IP 75MG EXCIPIENTS Q.S. COLOUR : IRON OXIDE RED & TITANIUM DIOXIDE IP | IP |
606 | DICLOFENAC SODIUM SUSTAINED RELEASE TABLET IP | EACH SUSTAINED RELEASE FILM COATED TABLET CONTAINS DICLOFENAC SODIUM IP 150 MG EXCIPIENTS Q.S. COLOUR : IRON OXIDE RED & TITANIUM DIOXIDE IP | IP |
607 | ROSUVASTATIN TABLET IP | EACH FILM COATED TABLET CONTAINS ROSUVASTATIN CALCIUM IP EQ. TO ROSUVASTATIN 20 MG EXCIPIENTS Q.S. COLOUR : FERRIC OXIDE & TITANIUM DIOXIDE IP | IP |
608 | ROSUVASTATIN TABLET IP | EACH FILM COATED TABLET CONTAINS ROSUVASTATIN CALCIUM IP EQ. TO ROSUVASTATIN 40 MG EXCIPIENTS Q.S. COLOUR : FERRIC OXIDE & TITANIUM DIOXIDE IP | IP |
609 | DAPAGLIFLOZIN TABLETS 10 MG | EACH FILM COATED TABLETS CONTAINS DAPAGLIFLOZIN 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
610 | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE (SR) TABLET | EACH UNCOATED TABLET CONTAINS: PIOGLITAZONE HYDROCHLORIDE IP EQ. TO PIOGLITAZONE 15 MG METFORMIN HYDROCHLORIDE IP 500 MG (IN A SUSTAINED RELEASE FORM) EXCIPIENTS Q.S. COLOUR: YELLOW OXIDE OF IRON | |
611 | ROSUVASTATIN AND CLOPIDOGREL TABLET | EACH FILM COATED TABLET CONTAINS: ROSUVASTATIN CALCIUM IP EQ. TO ROSUVASTATIN 10 MG CLOPIDOGREL BISULPHATE IP EQ. CLOPIDOGREL 75 MG EXCIPIENT Q.S. COLOUR: FERRIC OXIDE & TITANIUM DIOXIDE IP | |
612 | ROSUVASTATIN AND CLOPIDOGREL TABLET | EACH FILM COATED TABLET CONTAINS: ROSUVASTATIN CALCIUM IP EQ. TO ROSUVASTATIN 20 MG CLOPIDOGREL BISULPHATE IP EQ. CLOPIDOGREL 75 MG EXCIPIENT Q.S. COLOUR: FERRIC OXIDE , TITANIUM DIOXIDE IP | |
613 | ATORVASTATIN TABLETS IP | EACH FILM COATED TABLET CONTAINS: ATORVASTATIN CALCIUM IP EQ. TO ATORVASTATIN 5 MG EXCIPIENTS Q.S. COLOUR: BRILLIANT BLUE LAKE & TITANIUM DIOXIDE IP | IP |
614 | ATORVASTATIN TABLETS IP | EACH FILM COATED TABLET CONTAINS:: ATORVASTATIN CALCIUM IP EQ. TO ATORVASTATIN 40 MG EXCIPIENTS Q.S. COLOUR: BRILLIANT BLUE LAKE & TITANIUM DIOXIDE IP | IP |
615 | ATORVASTATIN & FENOFIBRATE TABLETS IP | EACH FILM COATED TABLET CONTAINS:: ATORVASTATIN CALCIUM IP EQ. TO ATORVASTATIN 10 MG FENOFIBRATE IP 160 MG EXCIPIENTS Q.S. COLOUR: LAKE INDIGO CARMINE & TITANIUM DIOXIDE IP | IP |
616 | ATORVASTATIN & FENOFIBRATE TABLETS IP | EACH FILM COATED TABLET CONTAINS: : ATORVASTATIN CALCIUM IP EQ. TO ATORVASTATIN 20 MG FENOFIBRATE IP 160 MG EXCIPIENTS Q.S. COLOUR: LAKE INDIGO CARMINE & TITANIUM DIOXIDE IP | IP |
617 | ATORVASTATIN & FENOFIBRATE TABLETS IP | EACH FILM COATED TABLET CONTAINS: : ATORVASTATIN CALCIUM IP EQ. TO ATORVASTATIN 40 MG FENOFIBRATE IP 160 MG EXCIPIENTS Q.S. COLOUR: LAKE INDIGO CARMINE & TITANIUM DIOXIDE IP | IP |
618 | BISOPROLOL FUMARATE TABLETS USP | EACH FILM COATED TABLET CONTAINS: BISOPROLOL FUMARATE USP 5 MG COLOUR : FERRIC OXIDE USP NF& TITANIUM DIOXIDE IP | USP |
619 | BISOPROLOL FUMARATE TABLETS USP | EACH FILM COATED TABLET CONTAINS: BISOPROLOL FUMARATE USP 2.5 MG COLOUR : FERRIC OXIDE USP NF& TITANIUM DIOXIDE IP | USP |
620 | DRIED ALUMINIUM HYDROXIDE, MAGNESIUM ALUMINIUM SILICATE HYDRATE, MAGNESIUM HYDROXIDE & SIMETHICONE TABLETS | EACH UNCOATED CHEWABLE TABLET CONTAINS: DRIED ALUMINIUM HYDROXIDE GEL IP 300 MG MAGNESIUM ALUMINIUM SILICATE HYDRATE 50 MG MAGNESIUM HYDROXIDE IP 25 MG SIMETHICONE IP 25 MG COLOUR :SUNSET YELLOW FCF | |
621 | ASPIRIN GASTRO-RESISTANT TABLET IP 75 MG | EACH GASTRO-RESISTANT TABLET CONTAINS:: ASPIRIN IP 75 MG COLOUR: LAKE OF SUNSET YELLOW FCF & TITANIUM DIOXIDE IP | IP |
622 | FOLIC ACID TABLET IP 5 MG | EACH UNCOATED TABLET CONTAINS: FOLIC ACID IP 5 MG EXCIPIENT Q.S. | IP |
623 | HYDROXYCHLOROQUINE TABLETS IP | EACH FILM COATED TABLET CONTAINS: HYDROXYCHLOROQUINE SULPHATE IP 200 MG COLOUR: TITANIUM DIOXIDE IP | IP |
624 | NIFEDIPINE SUSTAINED RELEASE TABLETS IP 30 MG | EACH FILM COATED SUSTAINED RELEASE TABLET CONTAINS NIFEDIPINE IP 30 MG EXCIPIENTS Q.S. COLOUR: SUNSET YELLOW | IP |
625 | NIFEDIPINE SUSTAINED RELEASE TABLET IP 10 MG | EACH SUSTAINED RELEASE FILM COATED TABLET CONTAINS: NIFEDIPINE IP 10 MG EXCIPIENTS Q.S. COLOUR: SUNSET YELLOW FCF | IP |
626 | NIFEDIPINE SUSTAINED RELEASE TABLET IP 60 MG | EACH SUSTAINED RELEASE FILM COATED TABLET CONTAINS: NIFEDIPINE IP 60 MG EXCIPIENTS Q.S. COLOUR: SUNSET YELLOW FCF | IP |
627 | SILVER NITRATE GEL 0.2% W/W | COMPOSITION: SILVER NITRATE IP 0.2% W/W ETHYL ALCOHOL IP 4% V/V GEL BASE Q.S. | |
628 | NANOCRYSTALLINE SILVER GEL | COMPOSITION: EACH GRAM OF GEL CONTAINS: SILVER AS NANO PARTICLES 0.002 % PERFUMED GEL BASE Q.S. COLOUR: CARMOISINE | |
629 | SILDENAFIL CITRATE AND DAPOXETINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: SILDENAFIL CITRATE IP EQ. TO SILDENAFIL 50 MG DAPOXETINE HYDROCHLORIDE IP EQ. TO DAPOXETINE 30 MG EXCIPIENTS Q.S. COLOUR: BRILLIANT BLUE LAKE, QUINOLINE YELLOW LAKE, IRON OXIDE BLACK & TITANIUM DIOXIDE | |
630 | TADALAFIL AND DAPOXETINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: TADALAFIL IP 10 MG DAPOXETINE HYDROCHLORIDE IP EQ. TO DAPOXETINE 30 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
631 | OMEPRAZOLE MAGNESIUM & DOMPERIDONE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: OMEPRAZOLE MAGNESIUM IP EQ TO OMEPRAZOLE 20 MG DOMPERIDONE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED | |
632 | GLIBENCLAMIDE & METFORMIN HYDROCHLORIDE (SR) TABLETS IP | EACH UNCOATED BILAYERED TABLETS CONTAINS: GLIBENCLAMIDE IP 2.5 MG METFORMIN HYDROCHLORIDE IP 400 MG EXCIPIENTS Q.S COLOUR : RED OXIDE OF IRON | IP |
633 | ATORVASTATIN, CLOPIDOGREL AND ASPIRIN CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: ATORVASTATIN CALCIUM IP (AS PELLETS) EQ. TO ATORVASTATIN 20 MG CLOPIDOGREL BISULPHATE IP (AS PELLETS) EQ. TO CLOPIDOGREL 75 MG ASPIRIN IP 75 MG (AS GASTRO-RESISTANT PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL. | |
634 | PARACETAMOL EXTENDED RELEASE TABLETS 650 MG | EACH UNCOATED BILAYERED TABLET CONTAINS: PARACETAMOL IP 325 MG (AS IMMEDIATE RELEASE) PARACETAMOL IP 325 MG (AS EXTENDED RELEASE) APPROVED COLOUR USED | |
635 | SILODOSIN 8 MG TABLETS | EACH FILM COATED TABLET CONTAINS: SILODOSIN 8 MG EXCIPIENTS Q.S. COLOUR: LAKE SUNSET YELLOW FCF | |
636 | LEVOCETIRIZINE DIHYDROCHLORIDE DISPERSIBLE TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: LEVOCETIRIZINE HYDROCHLORIDE IP 5 MG EXCIPIENTS Q.S. | |
637 | METHYLPREDNISOLONE TABLETS IP | EACH UNCOATED TABLET CONTAINS METHYLPREDNISOLONE IP 4 MG EXCIPIENTS Q.S. | IP |
638 | SAXAGLIPTIN TABLETS 5 MG | EACH FILM COATED TABLET CONTAINS SAXAGLIPTIN HYDROCHLORIDE EQ. TO SAXAGLIPTIN 5 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON & TITANIUM DIOXIDE IP | |
639 | SAXAGLIPTIN TABLETS 2.5 MG | EACH FILM COATED TABLET CONTAINS SAXAGLIPTIN HYDROCHLORIDE EQ. TO SAXAGLIPTIN 2.5 MG EXCIPIENTS Q.S. COLOUR: YELLOW OXIDE OF IRON & TITANIUM DIOXIDE IP | |
640 | TAPENTADOL HYDROCHLORIDE TABLETS | EACH FILM COATED TABLETS CONTAINS TAPENTADOL HYDROCHLORIDE EQ. TO TAPENTADOL 100 MG EXCIPIENTS Q.S. COLOUR: SUNSET YELLOW FCF | |
641 | ACECLOFENAC, LINSEED OIL,MENTHOL , METHYL SALICYLATE & CAPSAICIN GEL | COMPOSITION ACECLOFENAC BP 1.5% W/W LINSEED OIL (OLEUM LINI) BP 3.00% W/W MENTHOL BP 5.00% W/W METHYL SALICYLATE BP 10.00% W/W CAPSAICIN USP 0.025%W/W BENZYL ALCOHOL BP 0.1 % W/W GEL BASE | |
642 | AMITRIPTYLINE HYDROCHLORIDE AND CHLORDIAZEPOXIDE TABLETS | EACH FILM COATED TABLET CONTAINS AMITRIPTYLINE HYDROCHLORIDE IP EQ TO AMITRIPTYLINE 12.5 MG CHLORDIAZEPOXIDE IP 5 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP | |
643 | TELMISARTAN AND METOPROLOL SUCCINATE PROLONGED-RELEASE TABLETS | EACH UNCOATED BILAYERED TABLET CONTAINS TELMISARTAN IP 40 MG METOPROLOL SUCCINATE IP 47.5 MG EQ. TO METOPROLOL TARTRATE 50 MG (AS PROLONGED-RELEASE) EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON | |
644 | TELMISARTAN AND METOPROLOL SUCCINATE PROLONGED-RELEASE TABLETS | EACH UNCOATED BILAYERED TABLET CONTAINS TELMISARTAN IP 40 MG METOPROLOL SUCCINATE IP 23.75 MG EQ. TO METOPROLOL TARTRATE 25 MG (AS PROLONGED-RELEASE) EXCIPIENTS Q.S. COLOUR: YELLOW OXIDE OF IRON | |
645 | AMITRIPTYLINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS AMITRIPTYLINE HYDROCHLORIDE IP EQ TO AMITRIPTYLINE 75 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP | |
646 | ESOMEPRAZOLE TABLETS (WITH SODIUM BICARBONATE AS BUFFER) | EACH FILM COATED TABLET CONTAINS ESOMEPRAZOLE MAGNESIUM TRIHYDRATE IP EQ. TO ESOMEPRAZOLE 40 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP | |
647 | PANTOPRAZOLE & DOMPERIDONE MALEATE TABLETS | EACH ENTERIC COATED TABLET CONTAINS PANTOPRAZOLE SODIUM IP EQ. TO PANTOPRAZOLE 40 MG DOMPERIDONE MALEATE IP EQ. TO DOMPERIDONE 30 MG EXCIPIENTS Q.S. COLOUR: YELLOW OXIDE OF IRON | |
648 | PANTOPRAZOLE & DOMPERIDONE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS PANTOPRAZOLE SODIUM IP EQ. TO PANTOPRAZOLE 40 MG (AS ENTERIC COATED) PELLETS DOMPERIDONE MALEATE IP EQ. TO DOMPERIDONE 30 MG (10 MG IMMEDIATE RELEASE AND 20 MG AS SUSTAINED RELEASE) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL AND PELLETS | |
649 | RAMIPRIL TABLETS IP 10 MG | EACH UNCOATED TABLET CONTAINS: RAMIPRIL IP 10 MG EXCIPIENTS Q.S. | IP |
650 | CARVEDILOL PHOSPHATE EXTENDED RELEASE TABLETS | EACH UNCOATED EXTENDED RELEASE TABLETS CONTAINS: CARVEDILOL PHOSPHATE 10 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP | |
651 | CARVEDILOL PHOSPHATE EXTENDED RELEASE TABLETS | EACH UNCOATED EXTENDED RELEASE TABLETS CONTAINS: CARVEDILOL PHOSPHATE 20 MG EXCIPIENTS Q.S. COLOUR: QUINOLINE YELLOW LAKE | |
652 | AMISULPRIDE TABLETS IP 400 MG | EACH FILM COATED TABLET CONTAINS: AMISULPRIDE IP 400 MG EXCIPIENTS Q.S. COLOUR: SUNSET YELLOW LAKE | IP |
653 | DICLOFENAC SODIUM TABLETS IP | EACH ENTERIC COATED TABLET CONTAINS: DICLOFENAC SODIUM IP 50 MG EXCIEPINTS Q.S. COLOUR: SUNSET YELLOW | IP |
654 | CHLORTHALIDONE 6.25 MG & METOPROLOL SUCCINATE EXTENDED RELEASE 25 MG TABLETS | EACH FILM COATED BILAYERED TABLETS CONTAINS CHLORTHALIDONE IP 6.25 MG METOPROLOL SUCCINATE IP 23.75 MG EQ. TO METOPROLOL TARTRATE 25 MG (AS EXTENDED RELEASE PART) COLOUR: INDIGO CARMINE & QUINOLINE YELLOW WS | |
655 | NIFEDIPINE EXTENDED RELEASE TABLETS USP 60 MG | EACH FILM COATED EXTENDED RELEASE TABLET CONTAINS NIFEDIPINE USP 60 MG EXCIPIENTS Q.S. COLOUR: FERRIC OXIDE YELLOW USP & TITANIUM DIOXIDE BP | USP |
656 | TADALAFIL AND DAPOXETINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: TADALAFIL IP 20 MG DAPOXETINE HYDROCHLORIDE IP EQ. TO DAPOXETINE 30 MG EXCIPIENTS Q.S. COLOUR:QUINOLINE YELLOW | |
657 | RAMIPRIL AND AMLODIPINE TABLETS | EACH UNCOATED TABLET CONTAINS RAMIPRIL IP 2.5 MG AMLODIPINE BESYLATE IP EQUIVALENT TO AMLODIPINE 5 MG EXCIPIENTS Q.S. COLOUR:TITANIUM DIOXIDE BP | |
658 | RAMIPRIL & HYDROCHLOROTHIAZIDE TABLETS | EACH UNCOATED TABLET CONTAINS RAMIPRIL IP 5 MG HYDROCHLOROTHIAZIDE IP 12.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USE | |
659 | MODAFINIL TABLETS IP | EACH UNCOATED TABLET CONTAINS MODAFINIL IP 100 MG EXCIPIENTS Q.S. | IP |
660 | TORSEMIDE TABLETS IP 40 MG | EACH UNCOATED TABLET CONTAINS TORSEMIDE IP 40 MG EXCIPIENTS Q.S. | IP |
661 | TORSEMIDE TABLETS IP 100 MG | EACH UNCOATED TABLET CONTAINS TORSEMIDE IP 100 MG EXCIPIENTS Q.S. | IP |
662 | CINITAPRIDE TABLETS 1 MG | EACH UNCOATED TABLET CONTAINS CINITAPRIDE HYDROGEN TARTRATE EQUIVALENT TO CINITAPRIDE 1 MG EXCIPIENTS Q.S. | |
663 | OLMESARTAN MEDOXOMIL AND CHLORTHALIDONE TABLETS | EACH FILM COATED BILAYERED TABLET CONTAINS OLMESARTAN MEDOXOMIL IP 40 MG CHLORTHALIDONE IP 6.25 MG EXCIPIENTS Q.S. COLOUR:SUNSET YELLOW | |
664 | OLMESARTAN AND CHLORTHALIDONE TABLETS | EACH FILM COATED TABLET CONTAINS CHLORTHALIDONE IP 12.5 MG OLMESARTAN MEDOXOMIL IP 40 MG EXCIPIENTS Q.S. COLOUR:PONCEAU 4R | |
665 | OLMESARTAN AND CHLORTHALIDONE TABLETS | EACH FILM COATED TABLET CONTAINS CHLORTHALIDONE IP 12.5 MG OLMESARTAN MEDOXOMIL IP 20 MG EXCIPIENTS Q.S. COLOUR:QUINOLINE YELLOW | |
666 | CHLORTHALIDONE AND OLMESARTAN MEDOXOMIL TABLETS | EACH FILM COATED TABLET CONTAINS CHLORTHALIDONE IP 6.25 MG OLMESARTAN MEDOXOMIL IP 20 MG EXCIPIENTS Q.S. APPROVED COLOUR USE | |
667 | CILNIDIPINE AND OLMESARTAN MEDOXOMIL TABLETS | EACH FILM COATED TABLET CONTAINS CILNIDIPINE IP 10 MG OLMESARTAN MEDOXOMIL IP 20 MG EXCIPIENTS Q.S. APPROVED COLOUR USE | |
668 | CARBIMAZOLE TABLETS IP | EACH UNCOATED TABLET CONTAINS CARBIMAZOLE IP 5 MG EXCIPIENTS Q.S. APPROVED COLOUR USE | IP |
669 | PARACETAMOL IMMEDIATE RELEASE 300 MG & SUSTAINED RELEASE 700 MG | EACH UNCOATED BIAYERED TABLET PARACETAMOL IP 300 MG (AS IMMEDIATE RELEASE) PARACETAMOL IP 700 MG (AS SUSTAINED RELEASE) EXCIPIENTS Q.S. APPROVED COLOUR USE | |
670 | MINOXIDIL TOPICAL SOLUTION USP 10% W/V | COMPOSITION MINOXIDIL IP 10.0%W/V ABSOLUTE ALCOHOL CONTENT 40.0%V/V | USP |
671 | FLUOXETINE HCL CAPSULES IP 60 MG | EACH HARD GELATINE CPASULES CONTAINS FLUOXETINE HYDROCHLORIDE IP EQUIVALENT TO FLUOXETINE 60 MG | IP |
672 | BECLOMETHASONE DIPROPIONATE, PHENYLEPHRINE HYDROCHLORIDE & LIDOCAINE HYDROCHLORIDE CREAM | COMPOSITION: BECLOMETHASONE DIPROPIONATE IP 0.025 % W/W PHENYLEPHRINE HYDROCHLORIDE IP 0.10W/W LIDOCAINE HYDROCHLORIDE IP 2.50%W/W CREAM BASE Q.S. | |
673 | RIVAROXABAN TABLETS 20 MG | EACH FILM COATED TABLET CONTAINS RIVAROXABAN 20 MG EXCIPIENTS Q.S. COLOUR:IRON OXIDE RED & TITANIUM DIOXIDE | |
674 | RANOLAZINE EXTENDED RELEASE TABLETS 1000 MG | EACH FILM COATED EXTENDED RELEASE TABLET CONTAINS RANOLAZINE 1000 MG EXCIPIENTS Q.S. COLOUR:IRON OXIDE RED | |
675 | EPLERENONE TABLETS | EACH FILM COATED TABLET CONTAINS EPLERENONE IP 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USE | |
676 | NICOUMALONE TABLETS IP | EACH UNCOATED TABLET CONTAINS NICOUMALONE IP 2 MG EXCIPIENTS Q.S. | IP |
677 | NICOUMALONE TABLETS IP | EACH UNCOATED TABLET CONTAINS NICOUMALONE IP 3 MG EXCIPIENTS Q.S. COLOUR:QUINOLINE YELLOW | IP |
678 | RANITIDINE HYDROCHLORIDE TABLETS IP | EACH FILM COATED TABLET CONTAINS RANITIDINE HYDROCHLORIDE IP EQUIVALENT TO RANITIDINE 300 MG EXCIPIENTS Q.S. COLOUR:SUNSET YELLOW FCF & TITANIUM DIOXIDE IP | IP |
679 | BRIVARACETAM TABLETS 100 MG | EACH FILM COATED TABLET CONTAINS BRIVARACETAM 100 MG EXCIPIENTS Q.S. COLOUR : TITANIUM DIOXIDE IP | |
680 | FAROPENEM TABLETS JP 200 MG | EACH FILM COATED TABLET CONTAINS FAROPENEM SODIUM HYDRATE IP EQUIVALENT TO FAROPENEM 200 MG EXCIPIENTS Q.S. COLOUR: FERRIC OXIDE USP NF RED FERRIC OXIDE USP NF YEW & TITANIUM DIOXIDE IP | JP |
681 | GLIMEPRIDE, VOGLIBOSE & METFORMIN HYDROCHLORIDE SUSTAINED RELEASE TABLETS | EACH FILM COATED BILAYERED SUSTAINED RELEASE TABLETS GLIMEPRIDE IP 2 MG VOGLIBOSE IP 0.2 MG METFORMIN HYDROCHLORIDE IP 500 MG (IN SUSTAINED RELEASE FORM) EXCIPIENTS Q.S. COLOUR :TITANIUM DIOXIDE & ERYTHROSINE | |
682 | ACEBROPHYLLINE 100 MG + N-ACETYLCYSTEINE 600 MG TABLETS | EACH FILM COATED BILAYERED TABLET CONTAINS ACEBROPHYLLINE 100 MG N-ACETYLCYSTEINE BP 600 MG EXCIPIENTS Q.S. COLOUR : QUINOLINE YELLOW | |
683 | OLMESARTAN, AMLODIPINE & HYDROCHLOROTHIAZIDE TABLETS | EACH FILM COATED TABLET CONTAINS OLMESARTAN MEDOXOMIL IP 20 MG AMLODIPINE BESYLATE IP EQ.TO AMLODIPINE 5 MG HYDROCHLOROTHIAZIDE IP 12.5 MG EXCIPIENTS Q.S. COLOUR : TITANIUM DIOXIDE IP | |
684 | OLMESARTAN, AMLODIPINE & HYDROCHLOROTHIAZIDE TABLETS | EACH FILM COATED TABLET CONTAINS OLMESARTAN MEDOXOMIL IP 40 MG AMLODIPINE BESYLATE IP EQ.TO AMLODIPINE 5 MG HYDROCHLOROTHIAZIDE IP 12.5 MG EXCIPIENTS Q.S. COLOUR :SUNSET YELLOW | |
685 | SILDENAFIL CITRATE TABLETS IP | EACH FILM COATED TABLET CONTAINS SILDENAFIL CITRATE IP EQ.TO SILDENAFIL 25 MG EXCIPIENTS Q.S. COLOUR : RED OXIDE OF IRON | IP |
686 | ZOLPIDEM TARTRATE TABLETS IP | EACH FILM COATED TABLET CONTAINS ZOLPIDEM TARTRATE IP 10 MG EXCIPIENTS Q.S. COLOUR : TITANIUM DIOXIDE IP | IP |
687 | ACECLOFENAC AND PARACETAMOL SUSPENSION | EACH 5 ML CONTAINS ACECLOFENAC IP 50 MG PARACETAMOL IP 125 MG FLAVOURED SYRUP BASE Q.S. COLOUR: SUNSET YELLOW | |
688 | TAMSULOSIN HYDROCHLORIDE MODIFIED RELEASE TABLETS 0.4 MG | EACH FILM COATED TABLET CONTAINS TAMSULOSIN HYDROCHLORIDE IP 0.4 MG (AS MODIFIED RELEASE) EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP | |
689 | PREGABALIN SUSTAINED RELEASE & METHYLCOBALAMIN TABLETS | EACH UNCOATED TABLETS CONTAINS PREGABALIN IP 75 MG (IN SUSTAINED RELEASE FORM) METHYLCOBALAMIN IP 750 MCG EXCIPIENTS Q.S. COLOUR: PONCEAU 4R LAKE | |
690 | DOXYLAMINE SUCCINATE 20 MG, PYRIDOXINE HYDROCHLORIDE 20 MG & FOLIC ACID 5 MG TABLETS | EACH ENTERIC COATED TABLET CONTAINS DOXYLAMINE SUCCINATE BP 20 MG PYRIDOXINE HYDROCHLORIDE IP 20 MG FOLIC ACID IP 5 MG EXCIPIENTS Q.S. COLOUR: TARTRAZINE | |
691 | ALBENDAZOLE SUSPENSION IP | EACH 10 ML CONTAINS ALBENDAZOLE IP 400 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED | IP |
692 | SILODOSIN CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS SILODOSIN 8 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL. | |
693 | PANTOPRAZOLE GASTRO-RESISTANT AND DOMPERIDONE PROLONGED-RELEASE CAPSULES IP | EACH HARD GELATIN CAPSULE CONTAINS PANTOPRAZOLE SODIUM SESQUIHYDRATE IP EQ. TO PANTOPRAZOLE 40 MG (AS ENTERIC COATED PELLETS) DOMPERIDONE IP 30 MG (AS SUSTAINED-RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL AND PELLETS | IP |
694 | ASPIRIN GASTRO-RESISTANT AND ROSUVASTATIN CALCIUM CAPSULES IP | EACH HARD GELATIN CAPSULE CONTAINS: ROSUVASTATIN CALCIUM IP EQ. TO ROSUVASTATIN 10 MG ASPIRIN IP 75 MG (AS ENTERIC COATED) APPROVED COLOUR USED IN EMPTY CAPSULES SHELLS | IP |
695 | NICORANDIL TABLETS IP | EACH UNCOATED TABLET CONTAINS NICORANDIL IP 10 MG EXCIPIENTS Q.S. | IP |
696 | NICORANDIL TABLETS IP | EACH UNCOATED TABLET CONTAINS NICORANDIL IP 5 MG EXCIPIENTS Q.S | IP |
697 | CLOPIDOGREL AND ASPIRIN TABLETS IP | EACH FILM COATED BILAYERED TABLET CONTAINS CLOPIDOGREL BISULPHATE IP EQ. TO CLOPIDOGREL 75 MG ASPIRIN IP 75 MG (IN COATED FORM) EXCIPIENTS Q.S. COLOUR: LAKE OF SUNSET YELLOW | IP |
698 | CLOPIDOGREL AND ASPIRIN TABLETS IP | EACH FILM COATED BILAYERED TABLET CONTAINS CLOPIDOGREL BISULPHATE IP EQ. TO CLOPIDOGREL 75 MG ASPIRIN IP 150 MG (IN COATED FORM) EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON | IP |
699 | BACLOFEN TABLETS IP | EACH UNCOATED TABLET CONTAINS BACLOFEN IP 10 MG EXCIPIENTS Q.S. | IP |
700 | BACLOFEN TABLETS IP | EACH UNCOATED TABLET CONTAINS BACLOFEN IP 20 MG EXCIPIENTS Q.S. | IP |
701 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (SUSTAINED-RELEASE) TABLETS | EACH UNCOATED BILAYER TABLET CONTAINS DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE EQ. TO DAPAGLIFLOZIN 10 MG METFORMIN HYDROCHLORIDE IP 1000 MG (IN SUSTAINED-RELEASE FORM) EXCIPIENTS Q.S. | |
702 | ARTEMETHER & LUMEFENTRINE FOR ORAL SUSPENSION | EACH 5 ML (AFTER RECONSTITUTION) CONTAINS ARTEMETHER IP 20 MG LUMEFANTRINE USP 120 MG EXCIPIENTS Q.S. COLOUR: SUNSET YELLOW | |
703 | ARTEMETHER & LUMEFENTRINE FOR ORAL SUSPENSION | EACH 5 ML (AFTER RECONSTITUTION) CONTAINS ARTEMETHER IP 40 MG LUMEFANTRINE USP 240 MG EXCIPIENTS Q.S. COLOUR: TARTRAZINE YELLOW SUPRA | |
704 | BISOPROLOL FUMARATE TABLETS USP | EACH FILM COATED TABLET CONTAINS BISOPROLOL FUMARATE USP 5 MG EXCIPIENTS Q.S. COLOUR: FERRIC OXIDE USP NF (RED) & TITANIUM DIOXIDE IP | USP |
705 | BISOPROLOL FUMARATE TABLET USP | EACH FILM COATED TABLET CONTAINS BISOPROLOL FUMARATE IP 2.5 MG EXCIPIENTS Q.S. COLOUR: PONCEAU 4R LAKE & TITANIUM DIOXIDE IP | USP |
706 | BISOPROLOL FUMARATE TABLET USP | EACH FILM COATED TABLET CONTAINS BISOPROLOL FUMARATE IP 10 MG EXCIPIENTS Q.S. COLOUR: FERRIC OXIDE USP NF (YELLOW), FERRIC OXIDE USP NF (RED) & TITANIUM DIOXIDE IP | USP |
707 | SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDE TABLET | EACH FILM COATED TABLET CONTAINS SITAGLIPTIN PHOSPHATE MONOHYDRATE IP 64.25MG EQ. TO SITAGLIPTIN 50 MG METFORMIN HYDROCHLORIDE IP 500 MG EXCIPIENTS Q.S. COLOUR: IRON OXIDE RED, IRON OXIDE BLACK & TITANIUM DIOXIDE IP | |
708 | SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDE TABLET | EACH FILM COATED TABLET CONTAINS SITAGLIPTIN PHOSPHATE MONOHYDRATE IP 64.25MG EQ. TO SITAGLIPTIN 50 MG METFORMIN HYDROCHLORIDE IP 1000 MG EXCIPIENTS Q.S. COLOUR: IRON OXIDE RED, IRON OXIDE BLACK & TITANIUM DIOXIDE IP | |
709 | AMLODIPINE TABLETS IP | EACH UNCOATED TABLET CONTAINS AMLODIPINE BESYLATE IP EQ. TO AMLODIPINE 2.5 MG EXCIPIENTS Q.S. | IP |
710 | AMLODIPINE & ATENOLOL TABLETS IP | EACH UNCOATED TABLET CONTAINS AMLODIPINE BESYLATE IP EQ. TO AMLODIPINE 5 MG ATENOLOL IP 50 MG EXCIPIENTS Q.S. COLOUR: LAKE OF SUNSET YELLOW FCF | IP |
711 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (SUSTAINED-RELEASE) TABLETS | EACH UNCOATED BILAYER TABLET CONTAINS DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE EQ. TO DAPAGLIFLOZIN 10 MG METFORMIN HYDROCHLORIDE IP 1000 MG (IN SUSTAINED-RELEASE FORM) EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP | |
712 | GLIMEPIRIDE AND METFORMIN HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: GLIMEPIRIDE IP 1 MG METFORMIN HYDROCHLORIDE IP 500 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON | |
713 | GLIMEPIRIDE AND METFORMIN HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: GLIMEPIRIDE IP 2 MG METFORMIN HYDROCHLORIDE IP 500 MG EXCIPIENTS Q.S. COLOUR: QUINOLINE YELLOW | |
714 | AMLODIPINE TABLETS IP | EACH UNCOATED TABLET CONTAINS AMLODIPINE BESYLATE IP EQ. TO AMLODIPINE 5 MG EXCIPIENTS Q.S. | IP |
Showing 1 to 713 of 713 entries
Rated 4 out of 5
Excellent support and communication on completing the project and shown great degree of flexibility with changing timelines, guidance to team for implementation of solution.
Rated 4 out of 5
From my first contact with Xenobiotics I have found them to be a very impressive company. The expert knowledge, exceptional customer service, and attention to detail have been a refreshing change when compared to other companies in the industry. The ability to outsource select products to them has allowed us to meet our operational challenges. In all this Xenobiotics has been very flexible and supportive.
Rated 4 out of 5
Excellent support and communication on completing the project and shown great degree of flexibility with changing timelines, guidance to team for implementation of solution.
Rated 4 out of 5
From my first contact with Xenobiotics I have found them to be a very impressive company. The expert knowledge, exceptional customer service, and attention to detail have been a refreshing change when compared to other companies in the industry. The ability to outsource select products to them has allowed us to meet our operational challenges. In all this Xenobiotics has been very flexible and supportive.
Rated 4 out of 5
Excellent support and communication on completing the project and shown great degree of flexibility with changing timelines, guidance to team for implementation of solution.
Rated 4 out of 5
From my first contact with Xenobiotics I have found them to be a very impressive company. The expert knowledge, exceptional customer service, and attention to detail have been a refreshing change when compared to other companies in the industry. The ability to outsource select products to them has allowed us to meet our operational challenges. In all this Xenobiotics has been very flexible and supportive.
prev
next